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  Abstract 
In the past few years the interest in coagulase-negative staphylococci (CoNS) has 
significantly increased in human medicine. CoNS are common commensal colonisers of 
the human skin, although now also recognised as major nosocomial pathogens. Over the 
last decades, several studies have been carried out in order to understand the pathogenicity 
mechanisms of CoNS. The well known determinants in the pathogenesis of CoNS 
infections are their ability to form biofilms and an exceptional resistance to several 
antibiotics. Nevertheless, there is a lack of studies regarding the commensal lifestyle of 
these microorganisms. Additionally, it is now hypothesised that commensal bacteria might 
be a reservoir of pathogenic determinants. Therefore, the work described throughout this 
thesis was aimed to perform a phenotypic and genotypic characterisation of different CoNS 
species isolated from healthy Portuguese individuals. A total of 61 CoNS isolates, 
comprising 7 different species, were obtained and characterised at the level of biofilm 
formation and antibiotic susceptibility profiles. According to the results, biofilm formation 
ability and presence of biofilm-associated genes were commonly found features, 
highlighting their pivotal role in the colonising lifestyle of CoNS. This study also 
addressed the correlation between phenotypic and genotypic characteristics of biofilm 
formation, corroborating and raising questions about the importance of some genes in this 
process. Moreover, it was observed a great proportion of isolates with decreased 
susceptibility and multiple resistances to some important antibiotics. A significant 
association between antibiotic resistance and biofilm formation was also demonstrated, and 
some hypotheses about the nature of such association were provided. Lastly, the expression 
patterns of two biofilm-associated genes at two distinct biofilm developmental stages were 
determined, confirming their importance in the accumulative stage of biofilm formation. 
Overall, the results presented in this thesis indicate that staphylococcal skin flora might be 
an important reservoir of potentially pathogenic bacteria and, simultaneously, bring to light 
new perceptions about the molecular basis of staphylococcal biofilm formation, and the 
nature of the association between antibiotic resistance and biofilm formation.  
Keywords: antibiotic resistance; biofilm formation; biofilm-associated genes; coagulase 
negative staphylococci; gene expression; healthy individuals 
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Resumo 
Nos últimos anos, o interese médico em estafilococos coagulase-negativos (ECNs) 
aumentou significativamente. Os ECNs são colonizadores comuns da pele humana, embora 
sejam atualmente considerados patogénios nosocomiais importantes. Nas últimas décadas, 
diversos estudos foram realizados afim de perceber os mecanismos patogénicos destes 
micro-organismos. Os determinantes mais conhecidos na patogénese de infeções por ECNs 
são a sua capacidade de formar biofilmes e uma resistência excecional a diversos 
antibióticos. Todavia, existe uma falta de estudos referente ao estilo de vida comensal 
destes micro-organismos. Além disso, coloca-se atualmente a hipótese de bactérias 
comensais constituirem um reservatório de determinantes patogénicos. Desta forma, o 
trabalho descrito nesta tese visou uma caraterização fenotípica e genotípica de diferentes 
espécies de ECNs isoladas de indivíduos portugueses saudáveis. No total foram obtidos 61 
isolados, englobando 7 espécies distintas, sendo posteriormente caraterizados ao nível de 
formação de biofilme e de perfis de suscetibilidade a antibióticos. De acordo com os 
resultados, a capacidade de formação de biofilme e a presença de genes relacionados com 
este processo foram caracteristicas comummente encontradas, salientando o seu papel 
preponderante no estilo de vida comensal dos ECNs. Foi também abordada a correlação 
entre caracteristicas fenotípicas e genotípicas de formação de biofilme, corroborando e 
levantando questões sobre a importância de alguns genes neste processo. Adicionalmente, 
uma grande proporção de isolados apresentaram suscetibilidade reduzida e múltiplas 
resistências a alguns antibióticos importantes. Foi também demonstrada uma associação 
significativa entre resistência a antibióticos e formação de biofilme, pelo que algumas 
hipóteses sobre a natureza desta associação foram apresentadas. Por fim, foram 
determinados os padrões de expressão de dois genes associados com formação de biofilme 
em duas fases distintas deste processo, confirmando a sua importância na fase de 
acumulação do biofilme. No geral, os resultados apresentados nesta tese indicam que a 
flora estafilocócica da pele poderá constituir um importante reservatório de bactérias 
potencialmente patogénicas e, simultaneamente, apresentam novas perceções sobre a base 
molecular da formação de biofilme em ECNs e sobre a natureza da associação entre 
resistência a antibióticos e formação de biofilme. 
Palavras-chave: resistência a antibióticos, formação de biofilme, genes associados à 
formação de biofilme, estafilococos coagulase-negativos, expressão genética, indivíduos 
saudáveis 
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1.1. Staphylococci: from health to disease 
Taxonomically, coagulase-negative staphylococci (CoNS) represent a group of 
bacteria belonging to the genus Staphylococcus, family Staphylococcaceae. Currently, this 
genus comprises more than 40 species, and many of them are known to colonise humans 
(Euzeby, 2013; Euzeby, 1997). Microscopically, staphylococci appear as Gram-positive 
cocci (0.5-1.5 μm in diameter), occurring singly, in pairs and in irregular grape-like 
clusters. On a solid culture medium, staphylococcal species exhibit different colony 
morphologies. While Staphylococcus aureus produces large yellow colonies, 
Staphylococcus epidermidis and other CoNS species usually form relatively small white-
greyish colonies. In a culture medium supplemented with blood, staphylococcal species 
could also be classified according to their haemolytic properties. Staphylococci are non-
motile, non-spore forming and usually unencapsulated. From a biochemical point of view, 
most species are facultative anaerobes, catalase positive and oxidase negative. All 
staphylococci are coagulase-negative, with the exception of S. aureus (Götz et al., 2006). 
However, some strains belonging to S. intermedius, S. hyicus, and S. schleiferi species may 
also yield positive coagulase reactions. CoNS species can be differentiated into two groups 
according to novobiocin susceptibility test. Novobiocin-susceptible group includes S. 
epidermidis, S. haemolyticus, S. hominis, and S. lugdunensis among others, which are 
usually implicated in a wide range of infections. Novobiocin-resistant group includes S. 
saprophyticus, a common cause of urinary tract infections (Venkatesh et al., 2006). From a 
molecular perspective, the genome size of staphylococci is about 2000-3000 kb, with a 
GC-content of 30-39% (George and Kloos, 1994; Kloos et al., 1998). 
Staphylococci are widely disseminated in the environment, occupying specific 
ecological niches. They are found as part of the normal microflora of humans and other 
animals, and usually have a commensal relationship with their host. Staphylococci are also 
isolated from a wide range of foodstuff such as cheese, milk and meat, and from 
environmental sources such as air, soil and water (Heikens, 2005; Kloos and Schleifer, 
1986; Kloos, 1992; Coton 2010; Schleifer and Bell 2009). 
1.1.1. Role of CoNS in the human skin microflora 
The human skin microflora is defined as the microorganisms present on the  surface 
and within the deeper layers of the healthy skin, as well as in the hair follicles (Grice et al., 
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2009). The human skin harbours a wide range of microorganisms, namely bacteria, fungi 
and viruses (Figure 1.1).  
 
Among the most common bacterial colonisers of the human skin are CoNS, which 
share this environment with a wide range of other bacteria, especially those belonging to 
Corynebacterium and Propionibacterium genera. Most skin bacteria, however, cannot be 
cultured and some recent studies employing culture-independent methodologies have 
revealed a greater diversity of bacterial species present on the human skin than what was 
known before (Gao et al., 2007; Grice et al., 2009). 
Actually, the human skin represents a fairly harsh environment for microbial growth, 
mainly due to constant variations in temperature, acidity, and humidity, along with the 
presence of host antimicrobial peptides (AMPs). Moreover, the self-renewing nature of the 
skin makes permanent bacteria attachment very difficult (Kong and Segre, 2012).  
Figure 1.1. Cross-sectional view of human skin and microbial flora associated. Adapted from Nature Rev 
Microbiol (2011), 9(4):244-53.  
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Although the mechanisms associated with adaptation and colonisation of the skin are 
not fully understood, analysis of S. epidermidis genome revealed the carriage of several 
genes with predicted function in the protection from the harsh conditions found in the 
natural habitat of this microorganism (Gill et al., 2005; Zhang et al., 2003). For instance, 
the presence of sodium pumps and transport systems for osmoprotectants allow the growth 
of CoNS in environments with high salt concentrations and osmotic pressures (Gill et al., 
2005). Moreover, it was demonstrated that S. epidermidis and other CoNS species secrete 
an extracellular polymer, called poly-γ-glutamic acid (PGA), that appears to play an 
important role in the protection of CoNS from key components of innate host defence such 
as AMPs, as well as from high salt concentrations (Kocianova et al., 2005). 
The colonisation of the skin by CoNS does not usually pose a threat, and may even 
play a key function in the maintenance of the normal human skin microflora, inhibiting the 
colonisation by other pathogenic microorganisms (Otto, 2009). Recent studies 
demonstrated that S. epidermidis has an important function in skin immune defence 
through the production of small peptides, called phenol-soluble modulins (PSMs) (Cogen 
et al., 2010a; Cogen et al., 2010b). Their results suggested that PSMs interact with AMPs 
naturally found on the skin, enhancing the killing of some other gram-positive bacteria, 
such as S. aureus and Group A Streptococcus, without damaging the normal skin 
microflora.   
1.1.2. Role of CoNS in healthcare-associated infections  
According to the Centers for Disease Control and Prevention (CDC), a healthcare-
associated infection (HAI) is a localised or systemic condition (1) that results from an 
adverse reaction to the presence of an infectious agent(s) or its toxin(s), (2) that occurs 
during a hospital admission, (3) for which there is no evidence that the infection was 
present or incubating at the time of admission (Horan et al., 2008). 
HAIs are a significant cause of morbidity and mortality around the world and 
represent an increasing problem in modern medicine (Burke, 2003). Klevens et al. (2007) 
attempted to estimate the magnitude of HAIs and associated deaths in United States 
hospitals during 2002. The estimated number of HAIs obtained was approximately 1.7 
million (4.5%) and the estimated deaths caused by or associated with HAIs were 
approximately 99 000. In the European Union, over 4 million people acquire a HAI every 
year, resulting in approximately 37 000 deaths directly related with the infection. The 
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annual costs associated with these infections are estimated at approximately €7 billion, 
including direct costs only (ECDC, 2012). In developing countries, the situation is even 
worst, with the proportion of infected patients frequently exceeding 25% (Pittet et al., 
2008). In Portugal, the last survey in the field of infection control was conducted in 2012. 
From a total of 18 258 inpatients, the overall prevalence rate of HAI was 10.6% (Pina et 
al., 2013). In general, the high prevalence rates of HAI over the world result in prolonged 
hospital stays, long-term disability, increased resistance of microorganisms to 
antimicrobials, high costs for patients and their families, and a massive financial burden for 
health systems (WHO, 2011). 
The increasing use of invasive medical devices has been appointed as the major 
cause for such high frequency of HAIs (Richards et al., 2000; von Eiff et al., 2005). CoNS 
have been found to be one of the most frequently isolated microorganisms in the context of  
medical device-related infections (e.g., catheters systems, pacemakers, prosthetic joints and 
heart valves, and a range of other polymer and metal implants) (Durando et al., 2010; 
Kollef et al., 2008). As common members of the normal human microflora, CoNS are not 
usually pathogenic and develop a benign relationship with their host (Otto, 2009). 
Surprisingly, CoNS are now considered opportunistic pathogens, causing infection 
especially in immunocompromised individuals, such as premature newborns, patients with 
malignant diseases, intravenous drug abusers and hospitalised patients with indwelling 
medical devices (Vadyvaloo and Otto, 2005; Venkatesh et al., 2006). Taking this into 
account, CoNS have been included in the group of the most important nosocomial 
pathogens (Wisplinghoff et al., 2003).  
CoNS develop from commensal to pathogenic lifestyle only when external barriers, 
such as skin, are damaged due to wounds or implantation of foreign bodies (e.g. indwelling 
medical devices) (Longauerova, 2006). The indigenous microflora of the patients is 
frequently regarded as the main source of infection. The risk of contamination of medical 
devices by CoNS is high, since they make up a significant proportion of the normal human 
skin microflora (Otto, 2012). However, there is growing evidence that a large proportion of 
CoNS infections are also due to specific strains that are able to persist in hospital settings 
(Blum-Menezes et al., 2009; Miragaia et al., 2007; Widerstrom et al., 2006).  
Currently, CoNS are a well known cause of a wide range of human infections (Table 
1.1) (Piette and Verschraegen, 2009). Within CoNS group, S. epidermidis is by far the 
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most frequent etiological agent associated with those infections. However, other CoNS 
species, especially S. haemolyticus, S. lugdunensis and S. saprophyticus, are also 
associated with severe infectious diseases (Donlan and Costerton, 2002; Fredheim et al., 
2009; Shin et al., 2011). Other CoNS, such as S. capitis, S. caprae, S. hominis or S. 
warneri, are implicated in human infection, however, to a lesser extent (John and Harvin, 
2007). 
Table 1.1. Implication of CoNS in human infection 
Clinical conditions CoNS species References 
Bloodstream infections CoNS in general Munoz et al. (2004); Wisplinghoff et 
al. (2004) 
Endocarditis S. epidermidis (most frequent); S. hominis, S. lugdunensis, 
S. capitis, S. caprae, S. simulans (occasionally found) 
Chu et al. (2004); Wang et al. (2007) 
Endophtalmitis CoNS in general Karacal et al. (2007) 
Other foreign body-related 
infections 
S. epidermidis (most frequent); and other CoNS 
(occasionally found) 
Monsen et al. (2000); von Eiff et al. 
(2005) 
Surgical site infection CoNS in general Cantlon et al. (2006); CDC (1996) 
Urinary tract infections S. saprophyticus (most frequent); S. epidermidis 
and S.caprae (occasionally found) 
Raz et al. (2005); Widerstrom et al. 
(2007) 
1.1.3. Virulence factors of CoNS 
The pathogenic potential of a group of bacteria is determined by the combined effect 
of extracellular factors such as toxins, along with adhesive and invasive determinants 
mediated by components on the bacterial cell wall (Otto, 2004).  
While several virulence factors have been described for S. aureus, in CoNS only a 
few have been properly characterised. CoNS infections are seldom life-threatening as they 
do not produce many aggressive virulence factors. However, in immunocompromised 
patients these infections could develop into severe conditions (Goldman et al., 2001; 
Poutsiaka et al., 2007). Once CoNS reach the epithelial protective layer, they can be highly 
infectious. Persistence in the host and evasion of the immune machinery seem to be the 
pathogenic strategies employed by CoNS. This is mainly achieved by their striking ability 
to form a thick and multilayered biofilm (discussed in more detail in section 1.2) on the 
surface of indwelling medical devices. It is well established that microorganisms in this 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
7 
 
physiological state are highly resistant to antimicrobial treatments and can escape from the 
mechanisms of innate host defence (Cerca et al., 2006; Cerca et al., 2005; Cheung et al., 
2010). Hence, molecules involved in adhesion and biofilm formation are regarded as key 
virulence determinants of CoNS (Otto, 2009). Some of these determinants, however, also 
have functions in the commensal lifestyle of CoNS, since they are found on both clinical 
and commensal isolates (Kocianova et al., 2005; Rohde et al., 2004; Vuong et al., 2004). 
For this reason, there seems to be an increasing consensus about considering CoNS as 
“accidental” pathogens. Even though several virulence factors have been characterised, 
such as toxins (Cogen et al., 2010a; Cogen et al., 2010b), lipases (Longshaw et al., 2000) 
and proteases (Lai et al., 2007), the most important are definitely those related with biofilm 
formation (discussed in Chapter III). In Table 1.2 are summarised the most recognised 
virulence factors of S. epidermidis as it is by far the best studied CoNS species.  
Table 1.2. Main recognised virulence factors of S. epidermidis. Adapted from Nat Rev Microbiol (2009), 
7(8):555-67. 
Virulence factor Gene Function 
Biofilm factors  
Primary attachment to abiotic surfaces 
AtlE atlE 
Autolysin/ adhesin; affects surface hydrophobicity 
 
Aae Aae Autolysin/ adhesin 
Teichoic acids Multiple biosynthetic genes 
Affect attachment (only demonstrated in S. aureus, but with 
supposed similar function in CoNS) 
Primary attachment to matrix proteins (MSCRAMMs) 
SdrF sdrF Binds to collagen  
SdrG  (Fbe) sdrG (also known as fbe) Binds to fibrinogen 
SdrH sdrH Putative binding function only 
Embp Embp Binds to fibronectin 
AtlE and Aae atlE and aae Bind to several matrix proteins 
GehD gehD Binds to collagen 
Intercellular aggregation 
PIA (PNAG) icaA, icaD, icaB and icaC Polysaccharide intercellular adhesion 
Bhp Bhp Protein intercellular adhesion 
Aap Aap Protein intercellular adhesion 
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Table 1.2. (continuation) 
Virulence factor Gene Function 
Teichoic acids Multiple biosynthetic genes Components of the biofilm matrix  
Protective exopolymers 
PIA icaA, icaD, icaB and icaC Protects from IgG, AMPs, phagocytosis and complememt 
PGA capA, capB, capC and capD Protects from AMPs and phagocytosis 
Resistance to AMPs 
SepA protease sepA Involved in AMP degradation 
Aps system apsR, apsS and apsX This system senses AMPs and regulates AMP resistance mechanism 
Toxins 
PSMs psmα, psmδ, psmε, hld Pro-inflammatory cytolysins 
Exoenzymes   
Lipases GehC and GehD  gehC and gehD Possibly responsible for the persistence in fatty acid secretions 
Glutamylendopeptidase 
GluSE and serine 
proteases SspA and Esp 
sspA Degrades fibrinogen and complement factor C5 
Cysteine proteases SspB 
and Ecp 
sspB Possibly responsible for tissue damage 
Metalloprotease/ elastase 
SepA 
sepA 
Involved in lipase maturation, AMP resistance, and potential tissue 
damage 
Other factors 
Staphyloferrins A and B sfna locus Siderophores (iron acquisition) 
SitA, SitB and SitC  sitA,sitB and sitC Involved in iron uptake 
FAME Unidentified Inactivates host-produced bactericidal fatty acids 
AMP, antimicrobial peptide; Aap, accumulation-associated protein; Bhp, Bap homologue protein; FAME; fatty acid modifying 
enzyme; IgG, immunoglobulin G; MSCRAMM, microbial surface component recognizing adhesive matrix molecules; PGA, poli-γ-
glutamic acid; PIA, polysaccharide intercellular adhesin; PSM, phenol.soluble modulin. 
Despite being apparently harmless, several studies have shown that CoNS are able to 
produce factors that induce inflammatory responses or damage host tissues (Otto, 2004). 
With regards to toxins, and although not recognized as classical toxin producers, almost all 
CoNS strains are thought to produce PSMs which appear to have pro-inflamatory effect 
(Vuong et al., 2004). PSMγ (also known as δ-toxin) has been suggested to have cytolytic 
properties and several others share high sequence homology to S. aureus PSMs which have 
a prominent ability to lyse human neutrophils (Wang et al., 2007). Moreover, it has been 
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proposed that PSMs are also involved in the dispersion of bacteria from S. epidermidis 
biofilms (Vadyvaloo and Otto, 2005), which contributes for the persistence of CoNS 
infections. Nevertheless, their role in human infection is unclear as PSMs also play an 
important role in the commensal lifestyle of CoNS by competing with other bacteria on the 
skin, as previously stated in section 1.1.1.  
In the following introductory sections, the role of microbial biofilms in human 
infection is discussed in more detail as well as the issue of antibiotic resistance since these 
two intimately related fields are the basis for the experimental work described throughout 
this thesis.  
1.2. Microbial biofilms 
As previously discussed, biofilm formation is the major recognised virulence factor 
of CoNS. Nevertheless, this mode of growth is common throughout other bacterial genera 
and is not necessarily associated with disease. Actually, the majority of bacteria (about 
99%) are found naturally organised in biofilms (O'Gara and Humphreys, 2001). In this 
section a general model of biofilm formation as well as the role of biofilms in infectious 
diseases are described. 
1.2.1. General model of biofilm formation 
Although several definitions have been proposed during the last decades, a biofilm is 
usually referred as a structured community of microorganisms attached to an abiotic or 
living surface and embedded in a self-produced matrix of extracellular polymeric 
components, such as polysaccharides, proteins and nucleic acids (Donlan and Costerton, 
2002). It is well established that microorganisms in biofilm state have lower growth rate 
than in planktonic (free-floating) state. It is worth noting that microorganisms rarely live in 
environments containing high concentrations of nutrients and thus it is more advantageous 
growing in a biofilm (Cerca and Jefferson, 2012).  
There are slightly different models of the biofilm formation process according to the 
bacterial species involved. Nevertheless, they follow the same basic stepwise process 
(Figure 1.2): (1) primary attachment of cells to a surface, (2) accumulation of cells in 
multiple layers, (3) maturation and (4) detachment (Fey and Olson, 2010; Stoodley et al., 
2002).  Primary attachment of planktonic cells may occur in two distinct ways: (1a) direct 
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adhesion to the polymer surface, or (1b) adhesion to host matrix proteins that cover the 
polymer surface as a “conditioning film” (often associated with medical device-related 
infections) through interaction with specific bacterial binding proteins. This step comprises 
nonspecific and hydrophobic interactions. After this stage, bacteria multiply forming 
structures called microcolonies. This stage requires intercellular adhesion, which is 
achieved by the production of extracellular matrix in which the bacteria become 
surrounded. Then, maturation of the biofilm structure takes place with formation of 
channels for water, ion, and nutrient exchange, giving rise to the characteristic three-
dimensional appearance of biofilms. Finally, detachment and dispersal of single bacterial 
cells or large cell clusters occur, which may then initiate a new cycle of biofilm formation 
elsewhere (Rohde et al., 2006; Schoenfelder et al., 2010). 
1.2.2. Biofilms and infectious diseases 
Today it is recognised the huge impact of microbial biofilms in infectious diseases. It 
is estimated that biofilms are involved in at least 65% of all human infections (Lewis, 
2007). Moreover, the development of biofilms on medical devices accounts for a wide 
range of persistent infections. Up to 60% of all nosocomial infections are caused by 
biofilms on medical devices. As bacterial biofilms are highly recalcitrant to antimicrobial 
therapy, standard antibiotic therapy is often useless. Hence, the removal and replacement 
of the contaminated medical device is often required, which involves an additional 
economic and health cost (Donlan and Costerton, 2002).  
 
 
Figure 1.2. General model of biofilm formation showing the distinct phases of this process. 
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Although to a lesser extent, microorganisms can also adhere to natural surfaces (i.e. 
human tissues) and develop a biofilm which may be associated with several infections, 
such as otitis media (Hall-Stoodley et al., 2006), native valve endocarditis (Martin-Davila 
et al., 2005), cystic fibrosis (Bjarnsholt et al., 2009), periodontitis and caries (Zijnge et al., 
2010), chronic bacterial prostatitis (Mazzoli, 2010), and bacterial vaginosis (Swidsinski et 
al., 2005). 
Currently, it is not completely understood how biofilms provide a protective 
environment for bacteria in the host, although some important discoveries have been made 
in the past few years. The extracellular biofilm matrix is thought to play a key role in the 
protection of bacteria from phagocytosis and other elements of the host immune system. 
Nevertheless, some important studies have demonstrated that human leukocytes and 
antibodies can easily penetrate bacterial biofilms, even though they fail to phagocytise and 
kill the bacteria (Cerca et al., 2006; Leid et al., 2002). These results suggest that the 
increased resistance of biofilm cells to antibody-mediated phagocytosis may be due to high 
levels of antigens within the biofilm matrix, which subsequently inhibit antibody-mediated 
phagocytosis of the bacteria.  
The thickness of the biofilm also plays an important role in the protection of bacteria 
from reactive oxygen species and antibiotics. Very slow growth rates of biofilm cells 
appear to be responsible for resistance to classes of antibiotics whose efficiency is largely 
dependent on the growth rate of the cells, particularly cell wall synthesis inhibitors (Evans 
et al., 1991; Stewart, 1998). In fact, a study conducted by Cerca et al. (2005) demonstrated 
that cells in a biofilm are highly resistant to antibiotics that target cell wall synthesis, 
although are fairly susceptible to antibiotics that target RNA and protein synthesis. These 
are very interesting results since RNA and protein synthesis inhibitors are also dependent 
on the growth rate of the bacterial cells. Therefore, the resistance mechanisms of bacterial 
biofilms may not rely only on specific features associated with the biofilm phenotype, but 
also on the mechanism of action of the antibiotic. In fact, the mechanisms of antibiotic 
resistance in bacterial biofilms are only beginning to be elucidated. Figure 1.3 depicts the 
four leading hypotheses for mechanisms of antibiotic resistance in biofilms. 
As a conclusion, it is now clear that microbial biofilms pose a serious threat to the 
public health, with increasing importance in a wide range of infectious diseases, especially 
those related with the use of medical devices. 
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1.3. The issue of antibiotic resistance 
The beginning of antibiotic therapy was a successful period allowing the control of a 
wide range of infectious diseases (Levy, 2002). Since the discovery of penicillin in 1930s, 
several other antibiotics were discovered and produced in large scale. For this reason, 
antibiotics became a fundamental piece in the fight against infectious agents. Besides 
human medicine, other fields took advantage of the use of antibiotics, namely agriculture 
and livestock (Kummerer, 2004).  
Facing the increasing use of antibiotics over the last decades, bacteria have 
developed several mechanisms to cope with this scenario. Consequently, the emergence 
and dissemination of antibiotic resistance traits became inevitable and is currently regarded 
as a major public health issue (Levy and Marshall, 2004).  
 
Figure 1.3. Main hypothetical mechanisms of antibiotic resistance in biofilms. 
The images represent a cross section of a biofilm with the attachment surface (gray) at the bottom: (1) Slow 
penetration - the antibiotic (yellow) may fail to penetrate in the deeper layers of the biofilm; (2) Stress 
response - some of the bacteria within the biofilm may activate stress response (green dots); (3) Altered 
microenvironment - in zones where there is nutrient depletion or waste product accumulation (dark green), 
antibiotic action may be antagonised; (4) Persister cells - some bacteria may differentiate into a protected 
phenotype (red dots). 
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1.3.1. Factors promoting antibiotic resistance  
It is now clear that the massive use of antibiotics is crucial for the selection of 
resistant bacteria. Selection of resistant bacteria can occur during or after an antibiotic 
treatment (Beigi et al., 2004; Hurford et al., 2012), and due to the presence and wide 
dissemination of antibiotic resistance determinants (i.e. antibiotic molecules and resistance 
genes) into different ecological niches such as air, soil and water (Kummerer, 2003; 
Martinez, 2008; Wellington et al., 2013). Besides antibiotics, several other agents with 
bactericidal and/or bacteriostatic effects, many of them available in a wide range of 
household products (e.g. disinfectants), are also responsible for the selection of resistant 
bacteria (Levy, 2000; McMurry et al., 1998).   
The way antibiotics are available to the population plays an important role in the 
massive use of antibiotics currently observed and, subsequently, in the emergence of 
antibiotic resistance. Unfortunately, there are some parts of the world where antibiotics are 
simply sold on the street, and any person has access to them. On the other hand, in most 
developed countries a prescription is always required in order to get an antibiotic, yet this 
procedure seems not enough to prevent abusive consumption of antibiotics. In fact, most 
physicians are not acquainted or sensitive to the antibiotic resistance issue, and the 
prescription of antibiotics still remains a common option, even when its use is not 
necessary or adequate (Levy, 2002). 
Besides the massive use of antibiotics and the presence of resistance genes, most of 
resistance mechanisms employed by bacteria are not capable of destroying or inactivate 
antibiotic molecules. They rather rely on changing the target of the antibiotic or exporting 
it out of the bacterial cell (e.g. efflux pumps). Antibiotics are therefore released into the 
environment in their active form, allowing them to continue to exert their selective 
pressure in the bacterial populations (Levy and Marshall, 2004). 
1.3.2. Mechanisms of antibiotic resistance acquisition 
There are two essential factors to have in mind when dealing with the antibiotic 
resistance phenomenon: (1) the antibiotic, which acts as a selective agent and facilitates the 
spread of bacteria that possess resistance genes and (2) the resistance genes themselves 
(Levy, 2002). Since antibiotics and other related organic molecules are, or resemble, 
natural products, it is not unexpected to find resistance to newly discovered antibiotics. 
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Actually, bacteria have acquired several resistance mechanisms over their millennia of 
existence in order to deal with the wide range of molecules that constantly affect their 
growth (Dancer et al., 1997; Linares et al., 2006).  
Antibiotic resistance is normally classified as innate or acquired. Some bacterial 
species are intrinsically resistant to one or more classes of antibiotics due to physiological 
and structural features of the bacterial cell (Wright, 2010). Of greater concern are, 
however, the cases of acquired resistance, where initially susceptible bacterial populations 
become resistant to antibiotics, proliferating and disseminating under the selective pressure 
provided by such agents (Tenover, 2006). The process of acquired antibiotic resistance is 
quite complex, but it generally relies on two distinct mechanisms: genetic mutations and 
horizontal transfer of genes. The latter mechanism plays an important role in the 
dissemination of antibiotic resistance traits and may occur between strains of the same 
species or between different bacterial species or genera. Mechanisms of genetic exchange 
include conjugation (i.e. sexual transfer of DNA), transduction (i.e. bacteriophage transfer 
of DNA) and transformation (i.e. acquisition and incorporation of DNA released into the 
bacterial environment by lysis of other bacteria) (Tenover, 2006). Of the described gene 
transfer routes, transformation and conjugation appear to occur frequently among bacterial 
biofilms, although conjugation is possibly the more common mechanism in horizontal gene 
transfer (Tenover, 2006).  
In short, all the previously described mechanisms enable bacterial species to become 
quickly adapted to the introduction of antibiotics into their environment. In general, 
mechanisms of bacterial resistance rely on (1) changing or eliminating the binding site of 
the antibiotic, (2) up-regulating the production of enzymes that inactivate the antibiotic, (3) 
down-regulating or changing an outer membrane protein channel required by the antibiotic 
for cell entry, or (4) up-regulating efflux pumps that drive the antibiotic out of the bacterial 
cell (McManus, 1997). 
1.3.3. Reservoirs of antibiotic resistance and the role of commensal bacteria 
After use in humans or animals, antibiotics and any of their metabolites are 
discharged into the sewage system (Daughton and Ternes, 1999; Martinez, 2009). 
Depending on some physicochemical properties of these compounds (e.g. polarity, water 
solubility) they may be degraded, associate with sewage sludge, or released into the 
aquatic environment (e.g. rivers). Sewage sludge is often used as a fertiliser and may allow 
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the entrance of antibiotics into agricultural systems. Furthermore, antibiotics may also 
reach agricultural soils trough irrigation with wastewaters (Kinney et al., 2006). The soil 
ecosystem can subsequently transport these compounds to surface and ground waters 
allowing them to be cycled within the environment (Blackwell et al., 2007; Topp et al., 
2008). On the other hand, humans are constantly exposed to antibiotic resistance 
determinants by different manners: (1) crops exposed to contaminated sewage sludge, (2) 
livestock that have accumulated antibiotics and resistant microflora, (3) fish and shellfish 
exposed intentionally or unintentionally to antibiotic compounds, (4) contaminated surface 
and groundwater used for drinking water (Kummerer, 2004). Figure 1.4 outlines the 
dissemination paths of antibiotic resistance determinants and the relationship between 
different ecological niches. 
 When talking about the phenomenon of antibiotic resistance, it is important to note 
that both pathogenic bacteria and commensal microflora of humans and animals are 
affected. For instance, when an antibiotic therapy is applied, commensal bacteria are also 
affected by the selective pressures of such treatment and may become a major reservoir of 
Figure 1.4. The associations between potential environmental reservoirs of antibiotic resistance 
determinants. Adapted from Int J Antimicrob Agents (2000), 14(4):321-5. 
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resistant strains and resistance genes that could be horizontally transferred to pathogenic 
species (Marshall et al., 2009).  
Despite the potential role of commensal bacteria in providing a reservoir of antibiotic 
resistance, these bacterial communities have not been studied extensively. Moreover, 
information regarding antibiotic resistance in commensal and community-associated 
bacteria is still scarce. Nevertheless, many commensal bacterial species, previously 
regarded as relatively harmless residents of the human microflora, have recently emerged 
as multidrug-resistant microorganisms causing a wide range of infectious diseases in 
humans (Table 1.3) (Sommer et al., 2009). The increasing number of hospitalised, 
immunocompromised patients together with the widespread use and misuse of antibiotics 
have opened a door to the emergence of these “pathogenic” commensals (Jones et al., 
2008). Among this group of bacteria are CoNS, but also enterococci, streptococci and other 
Gram-negative microorganisms. 
Recognising the potential role of commensal bacteria as reservoirs of antibiotic 
resistance determinants, the Alliance for the Prudent Use of Antibiotics (APUA) began to 
examine this group of bacteria through its Reservoirs Of Antibiotic Resistance (ROAR) 
project (http://www.roarproject.org/). The aim of this project was, and still is, to encourage 
identification of commensal (usually non-pathogenic) strains as initial reservoirs of 
resistance traits before it appears in clinical strains. Since then, some studies on commensal 
bacteria have been made, and more questions than answers have arisen. 
Interestingly, some studies on commensal bacteria have reported that antibiotic 
resistance might not mirror antibiotic usage (Diaz-Mejia et al., 2002) and may even 
precede industrial-scale production and distribution of antibiotics (D'Costa et al., 2006). 
Moreover, it is possible that some molecules present in the environment could somehow 
mimic current antibiotics and provide a selective pressure in bacterial communities 
(Slaughter et al., 2001). These overall results may partially explain why antibiotic 
resistance is widely distributed, even within antibiotic-free environments (Pallecchi et al., 
2007). Conversely, a study conducted by Thaller et al. (2010) reported residual antibiotic 
resistance traits among commensal bacteria colonising wild animals from a remote area 
inhabited by humans and with no antibiotic exposure. Taking these data together, it 
becomes clear that humans and their activities could be the main factor in the 
contamination of the environment and subsequent selection of resistant bacteria.  
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Table 1.3. Emergence of antibiotic resistance in commensal bacteria causing infectious diseases. Adapted 
from Nature (2008), 451: 990-3. 
Species Disease Year Resistance 
Acinetobacter baumanii  
 
Nosocomial pneumonia, bacteremia, UTI, 
meningitis, septicemia 
1985  Imipenem 
1993 Gentamicin 
1998  MDRa 
2001  Polymixin 
Campylobacter jejuni  Campylobacteriosis 1986 Fluoroquinolone 
Clostridium difficile Clostridium difficile-associated diarrhea 1989 Clindamycin 
Enterococcus faecalis  
 
Endocarditis, bacteremia, catheter-related 
infection, intra-abdominal and pelvic infections. 
1978 Gentamicin 
1986 Vancomycin 
1989  Ampicillin 
1989  Penicillin 
2000  Linezolid 
Haemophilus influenzae 
 
Bacteremia, RTI, meningitis, osteoarthritis 
1972  Ampicillin 
1975  Chloramphenicol/ Tetracycline 
1975  Chloramphenicol 
1979  MDR 
1979  Chloramphenicol/ Ampicillin 
Klebsiella pneumoniae Pyogenic liver abcess, bacteremia, RTI 1983 Late-generation cephalosporins 
Pseudomonas aeruginosa 
 
Opportunistic infections in immunocompromised 
patients 
 
1985  Ceftazidime 
1987  Fluoroquinolone 
1988  Imipenem 
Staphylococcus 
epidermidis 
Infective endocarditis, catheter-related 
infections, bacteremia,  UTI, osteomyelitis, 
vascular graft infections, prosthetic 
joint infections 
1962 Methicillin 
1994  Rifampicin 
Staphylococcus 
haemolyticus 
Septicemia, peritonitis, UTI, infective 
endocarditis 
1984  Vancomycin 
1997  MDR 
Staphylococcus aureus  
 
Boils, furunculosis, pneumonia, 
mastitis, phlebitis, meningitis, 
UTI, osteomyelitis, endocarditis. 
 
1942  Penicillin 
1960  Methicillin 
1976  MDR 
2000  Vancomycin 
Streptococcus pneumoniae Streptococcus pneumonia infection 
1967 Tetracycline 
1977 MDR 
1978  Macrolide 
MDR, multidrug-resistant; RTI, respiratory tract infections; UTI, urinary tract infections. 
Another question that remains to be addressed is whether antibiotic use in agriculture 
and livestock activities is driving resistance genes from animal-associated bacteria into 
bacteria that cause human disease. Regarding to agriculture, large amounts of antibiotics 
are used (Heilig et al., 2002). Most food animals in developed countries are exposed to 
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antibiotics at some point during their lives. In this respect, antibiotics are used not only to 
treat or prevent some infectious diseases, but also to function as growth promoters or 
enhancers of feed efficiency. The main question here is that many antibiotics used in food 
animal production are the same as, or closely related to, that used in human medicine 
(McEwen and Fedorka-Cray, 2002). Moreover, the presence of resistance genes in ready-
to-eat food stuff may also serve as a source for the acquisition, by humans, of antibiotic-
resistant bacteria or associated resistance genes. The European Food Safety Authority 
(EFSA) recently reported that foodborne bacteria, including known pathogens and 
commensal bacteria, display an increasing and diverse range of resistance to several 
antimicrobial agents of human and veterinary importance (EFSA, 2008).  
Such diversity of sources for resistant bacteria and/ or resistance genes has an 
enormous epidemiological importance, as they may contribute to the accumulation of 
resistance determinants in human microflora. All these facts illustrate the impact of 
medical progression on antibiotic resistance and, most importantly, how usually harmless 
commensal bacteria are becoming into a truly threat to human health. 
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1.4. Outline and objectives of this thesis 
S. epidermidis and other CoNS species are now regarded as potential pathogenic 
microorganism. In addition, the morbidity and mortality rates as well as the costs 
associated with CoNS infections have reached frightening numbers during the past few 
years. Therefore, studies about this group of bacteria are urgently need and of extreme 
importance. On the other hand, the recognition of commensal bacteria as a reservoir of 
antibiotic resistance determinants is relatively recent. Hence, studies on commensal 
bacteria from different ecological niches are just now emerging. In fact, information about 
physiologic and genetic features of CoNS colonising healthy individuals in the community 
is scarce, and there is a serious lack of studies regarding CoNS isolated in Portugal.  
Taking into account all these factors, the main goal of this thesis was to perform a 
phenotypic and genotypic characterisation of CoNS isolated from healthy Portuguese 
individuals. This goal was achieved through the following tasks: 
1. Isolation of several CoNS species from healthy individuals (Chapter II); 
2. Evaluation of biofilm formation and correlation with the presence of biofilm-
associated genes (Chapter III); 
3. Evaluation of antibiotic susceptibility profiles and correlation with biofilm formation 
ability (Chapter IV); 
4. Analysis of biofilm-associated genes expression at different stages of S. epidermidis 
biofilm development (Chapter V). 
Lastly, this thesis is concluded by Chapter VI that describes the main conclusions 
drafted from this study, as well as possible future directions that should be addressed in 
order to answer some of the main questions that this work has raised. 
 
  
  
  
Chapter II 
Isolation and distribution of CoNS species on the skin of healthy 
individuals
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2.1. Introduction 
Staphylococcus spp. are usually identified based on colony morphology after culture 
onto solid medium. In contrast to other gram-positive cocci, such as enterococci and 
streptococci, all staphylococci are catalase positive. The optimum growth temperature is 
30ºC - 37ºC. Another important feature of staphylococci is that they usually thrive in 
media with high concentrations of sodium chloride (about 10%). However, not all catalase-
positive, Gram-positive cocci belong to the genus Staphylococcus. Micrococcus spp., also 
common colonisers of the human skin, are also catalase positive, and their cell shape and 
colony morphology usually resemble those of staphylococci (Engelkirk and Duben-
Engelkirk, 2008). There are currently some methods that allow the differentiation between 
staphylococci and micrococci, for instance the modified oxidase test. While all micrococci 
possess the enzyme cytochrome c oxidase, most staphylococci, with few exceptions, lack 
this enzyme (Faller and Schleifer, 1981). Another important clue that may help in the 
identification of microcci is their characteristic arrangement in tetrads after Gram staining. 
Furthermore, micrococci cells are usually larger than those of staphylococci (Engelkirk and 
Duben-Engelkirk, 2008) 
After the initial isolation procedure, the following step is the identification of 
presumptive staphylococci at the species level. Phenotypic methods are the most 
commonly used for CoNS species differentiation. These methods are based on biochemical 
reactions and, in most cases, easy to perform and cost-effectiveness. However, phenotypic 
identification of CoNS seems to be unsatisfactory and not completely reliable and 
reproducible. The main drawback of these methods is that there is some degree of 
variability in the expression of phenotypic features by isolates belonging to the same 
species (Grant et al., 1994; Heikens et al., 2005; Renneberg et al., 1995). 
To overcome the problems revealed by phenotypic methods, several molecular 
methods have been developed for CoNS species differentiation. DNA sequence-based 
methods targeting different housekeeping genes, such as 16S rRNA (Becker et al., 2004), 
dnaJ (Shah et al., 2007), gap (Ghebremedhin et al., 2008; Yugueros et al., 2000), hsp60 
(Goh et al., 1996), rpoB (Drancourt and Raoult, 2002; Mellmann et al., 2006), sodA 
(Poyart et al., 2001), and tuf (Hwang et al., 2011), are currently used for CoNS species 
identification. Comparatively with phenotypic methods, genotypic methods have higher 
discriminatory power, are independent of microbial growth, faster, and less laborious 
(Layer et al., 2006). Moreover, there is currently a large reference sequence database, 
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which makes genotypic identification of CoNS the most accurate method available 
(Zadoks and Watts, 2009).  
In routine clinical microbiology laboratories, CoNS are seldom identified to the 
species level, even when they are isolated from usually sterile biological specimens (e.g. 
blood or cerebrospinal fluid) (Weinstein et al., 1998). However, and taking into account 
the increasing importance of CoNS as nosocomial pathogens, it is crucial to study the 
epidemiology and the pathogenic determinants of each species. Moreover, there is 
evidence of species-related variation in the pathogenic potential, with some species being 
more pathogenic than others (Tan et al., 2006).  
2.1.1. Aims 
As discussed throughout the Chapter I, many of the recognised virulence factors of 
CoNS, especially those related with biofilm formation, are thought to play an important 
role in the commensal lifestyle of these microorganisms. Moreover, the recognition of 
commensal bacteria as reservoirs of antibiotic resistance determinants is relatively recent. 
To address these questions it is essential to gather a significant number of isolates so that 
we can thorough characterise them and draw significant conclusions.  
This chapter describes the isolation of commensal CoNS from the skin of Portuguese 
healthy individuals, and their identification at the species level using a DNA sequence-
based method targeting rpoB gene. 
2.2. Materials and methods 
2.2.1. Study area and population  
The present study was carried out in different cities of the Northern region of 
Portugal. The study was focused on healthy volunteers, preferentially with no contact with 
hospital environment. Participants were asked to provide skin swab samples and to 
complete a questionnaire recording demographic data (age, gender, occupation, and area of 
residence), hospitalisation history and antibiotic use (in the preceding 12 months), contact 
with hospital environment and/ or healthcare personnel, active smoking habits, allergic 
diseases and daily wash habits (Appendix A). All volunteers gave written informed 
consent (Appendix B). This study was approved by the Ethics Sub-commission for Health 
and Life Sciences of the University of Minho, Portugal (process SECVS 002/2013).  
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2.2.2. Sample collection and isolation procedures 
Skin swab samples from each participant were obtained by rubbing a sterile cotton-
tip transport swab with Amies transport medium and charcoal (VWR, Portugal) on the 
palm and between fingers of both hands. The swabs were inoculated on Tryptic Soy Agar 
(TSA) plates (Liofilchem, Teramo, Italy) supplemented with 7% sodium chloride (NaCl) 
(Sigma-Aldrich, USA) for selective growth of Staphylococcus spp.. After incubation for 
72h at 37ºC, colony morphology (including colour, shape, margin, elevation, and pigment 
characteristics) of all colonies were recorded. Colonies resembling CoNS were selected 
and streaked in fresh TSA plates until pure cultures were obtained.  
Preliminary identification of the isolates was achieved by means of classical 
microbiological methods: Gram staining, oxidase and catalase testing (Appendix C). 
Gram-positive cocci in clusters, catalase positive and oxidase negative were regarded as 
presumptive staphylococci and further studied. These isolates were stored at -80°C in TSB 
containing 20% (v/v) glycerol. Only one isolate per participant was included in the study, 
except for two subjects from whom two different CoNS species were isolated. 
2.2.3. Molecular identification of CoNS species 
DNA templates for PCR reactions were obtained by suspending five colonies of an 
overnight culture on TSA plates in 500 μl of sterile Mili-Q water (Milipore Corporation, 
MA, USA). The suspension was boiled at 100ºC for 20 minutes in thermal block, and then 
centrifuged at 15000 g for 5 minutes in order to pellet cells and insoluble debris. The 
supernatants were transferred to new tubes and stored at -20ºC until further use.  
Isolates were identified at the species level by partial rpoB gene sequencing, as 
previously described (Mellmann et al., 2006). PCR reactions were performed in a final 
volume of 60 μl according to the following conditions: 4 μl of DNA template, 30 μl of 
DyNAzyme II PCR Master Mix 2x (Finnenzymes, Thermo Scientific, Finland) 4 μl of 
primer mixture (10 μM of each forward and reverse primers) and 22 μl of nuclease-free 
water. PCR amplifications were performed using the MJ Mini thermal cycler (Bio-Rad, 
Hercules, CA, USA). Information about primers and amplification conditions is shown in 
Table 2.1. In each PCR run, a positive control (S. epidermidis ATCC 35984), and a 
negative control (water) were also included. Amplified products were analysed in 1% 
agarose gel stained with Midori Green DNA stain (Nippon Genetics Europe GmbH, 
Germany). The PCR products were purified using GRS PCR & Gel Band Purification Kit 
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(Grisp, Portugal) according to the instructions of the manufacturer. Sequencing of the 
purified PCR products was performed by the EUROFINS service (Eurofins MWG GmbH, 
Ebersberg, Germany) using the rpoB reverse primer.  
Table 2.1. Primers and amplification conditions for rpoB gene 
Target gene Oligonucleotide primers sequence (5’ to 3’) 
Amplicon 
size (bp) 
PCR conditions 
rpoB 
Fw: CAA TTC ATG GAC CAA GC 
899 
5 min at 94 °C; 
35 cycles of  45 s at 94 °C, 60 s at 52 °C and 
90 s at 72 °C 
10 min at 72 °C 
Rv: CCG TCC CAT GTC ATG AAA C 
bp, base pairs; Fw, forward; Rv, reverse 
2.2.4. Sequence alignments and phylogenetic analysis 
The nucleotide sequences of each isolate were analysed using two different web-
based alignment tools: (1) BLAST analysis (http://blast.ncbi.nlm.nih.gov/blast.cgi), and (2) 
BiBi Bio-informatic Bacterial identification analysis (http://umr5558-sud-str1.univ-
lyon1.fr/lebibi/lebibi.cgi). Identification at the species level was based on sequence 
similarity with the type strain of ≥97%. Phylogenetic trees were constructed based on rpoB 
sequences of all isolates. The nucleotide sequences were aligned using the ClustalX 
software, version 2.0 (Larkin et al., 2007). Phylogenetic trees were inferred with PHYLIP 
software package, version 3.69 (Felsenstein, 1989), using the maximum likelihood method. 
Tree figures were visualised with the FigTree software, version 1.4.0 (Rambaut, 2012). 
The DNA sequence similarity analysis was performed with BioEdit, version 7.2.0 (Hall, 
1999). 
2.3. Results and discussion 
2.3.1. Characterisation of study population 
A total of 59 subjects were included in the study with mean age of 23 (range 10-79) 
years. The age range with more volunteers was between 19-30 years (56%), indicating that 
a large proportion of the study population was composed by young people. Regarding the 
medical history collected, 37% reported having contact with medical staff and 5% were 
medical care employees, 12% were hospitalised in the preceding 12 months, and 25% were 
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under treatment with antibiotics during the same period. A more detailed characterisation 
of the study population is present in Table 2.2.  
Table 2.2. General characteristics of study population 
Characteristic n (%) Characteristic n (%) 
Socio-demographic characteristics Antibiotic use in the last year 15 (25) 
Age, years Contact with medical staff  22 (37) 
0-18 8 (14) Medical care employees 3 (5) 
19-30 33 (56) On medication 15 (25) 
31-50 10 (17) Allergic diseases 12 (20) 
51-79 8 (14) Daily habits 
Gender Hand washing with frequency 58 (98) 
Male 29 (49) Shower everyday 49 (83) 
Female 30 (51) 
Smoker/ exposure to tobacco 
smoke 
22 (37) 
Medical characteristics 
Tattoos/ acupuncture in the last 
year 
2 (3) 
Hospitalisations 11 (19) Gym/ pool/ sauna users 20 (34) 
In the last year 7 (12)   
2.3.2. Identification and distribution of CoNS species 
From the 59 swab samples included in this study, a group of 61 presumptive 
staphylococci was initially isolated. Identification at the species level based on partial rpoB 
gene sequence was successfully performed for all isolates, representing 7 different CoNS 
species.  
Sequence based analysis of rpoB, a conserved gene that encodes the β-subunit of the 
bacterial RNA polymerase, seems to have more discriminatory power than other target 
genes, especially 16S rRNA, in the identification of staphylococcal isolates at the species 
and subspecies level (Mellmann et al., 2006). Although it was not our aim to compare the 
discriminatory power between rpoB and other genes, our results demonstrate the suitability 
of this gene in the identification of the different staphylococcal species. As a result, rpoB 
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sequence-based identification may supplement, or even replace, phenotypic methods in the 
identification of staphylococcal species. Nevertheless, its effective use, especially in 
medical laboratories, requires the elaboration of a representative, publicly accessible 
reference database for sequence comparisons, as well as a clearly defined sequence 
similarity threshold for the correct identification of different species and subspecies 
(Hellmark et al., 2009). 
Regarding to the CoNS species found in this study, among the 61 CoNS isolates, 31 
(50.8%) were identified as S. epidermidis. Besides S. epidermidis, other CoNS species 
were isolated: S. capitis (n = 9, 14.8%), S. hominis (n = 8, 13.1%), S. warneri (n = 6, 
9.8%), S. haemolyticus (n = 4, 6.6%), S. equorum (n = 2, 3.3%) and S. pettenkoferi (n = 1, 
1.6%).  
It is well established that S. epidermidis is the predominant human staphylococcal 
species, comprising about 65-90% of all staphylococci isolated from human sources (Kloos 
and Musselwhite, 1975). Nevertheless, we found in this study a slightly lower proportion 
of S. epidermidis, despite representing more than half of all isolates. A similar study on 
community-associated CoNS isolates conducted by Widerstrom et al. (2011) reported the 
same rate. As previously stated in Chapter I, S. epidermidis has been identified as a major 
cause of HAIs, causing a wide range of infections, especially in patients with predisposing 
factors (e.g. indwelling or implanted foreign polymer bodies) (Piette and Verschraegen, 
2009). Other frequent human skin colonisers include S. capitis and S. hominis. S. capitis is 
mostly found on the head and is more frequently isolated during puberty, whereas S. 
hominis predominates on dry, glabrous skin (Kloos and Schleifer, 1975). Hence, the 
relatively high proportion of S. capitis and S. hominis isolates found in the present study is 
not surprising. Nevertheless, S. capitis was not only isolated from subjects within the 
puberty period, but also in older individuals. From a clinical point of view, S. capitis has 
been isolated from cases of endocarditis (Takano et al., 2011), and septicaemia (Ng et al., 
2006). With regards to S. hominis, and in contrast with S. epidermidis, a study using an 
animal infection model has shown that this species has low pathogenic potential (Lambe et 
al., 1990). Nevertheless, there are some studies reporting the involvement of S. hominis in 
severe clinical conditions, such as septicaemia (Chaves et al., 2005; Lindsay et al., 1993) 
or endocarditis (Cunha et al., 2007; Sunbul et al., 2006). Therefore, and taking into 
account all these aspects, care must be taken in the decision of clinical significance of these 
two CoNS species.  
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In the present study, S. warneri and S. haemolyticus were found to be less prevalent. 
According to previous studies, S. warneri and S. haemolyticus are less frequent colonisers 
of the human skin (Kloos and Schleifer, 1975; Schleifer and Kloos, 1975). Over the past 
decades, S. warneri has emerged as a harmful pathogen, able of causing infections 
associated, or not, with implant materials (Campoccia et al., 2010), and even in 
immunocompetent patients (Stollberger et al., 2006). Moreover, S. warneri has been 
occasionally involved in cases of meningitis (Incani et al., 2010), ventricular shunt 
infections (Martinez-Lage et al., 2010), and endocarditis (Kini et al., 2010). On the other 
hand, S. haemolyticus is an important multiresistant opportunistic pathogen in HAIs related 
to indwelling medical devices, representing the second most frequently isolated 
microorganism in infections due to CoNS (second only to S. epidermidis) (de Allori et al., 
2006; Viale and Stefani, 2006). Similarly to most CoNS species, S. haemolyticus is 
recognised by its ability to form biofilms, although it appears that these species also 
exhibits higher resistance rates to several classes of antibiotics (de Allori et al., 2006; 
Fredheim et al., 2009).  
S. equorum was originally isolated from the skin of healthy horses (Schleifer et al., 
1984). Only a few S. equorum strains were found in relevant human infections (Marsou et 
al., 2001; Nováková et al., 2006). However, it is known that humans may be transiently 
colonised by species that normally colonise other animals (Otto, 2010), which was also 
verified in the present study. 
Lastly, one isolate found in this study was identified as S. pettenkoferi, a newly 
recognised member of CoNS (Trulzsch et al., 2007). Although information about S. 
pettenkoferi is still limited, there are some reports of human infections caused by this 
microorganism, namely bloodstream infections (Mihaila et al., 2012; Song et al., 2009) 
and osteomyelitis (Loiez et al., 2007).  
2.3.3. Phylogenetic relationship between CoNS isolates  
The similarity of the rpoB sequences ranged from 64.9 to 99.7%, which was 
demonstrative of the discriminative power of the rpoB gene in CoNS identification. 
According to the phylogenetic analysis by maximum-likelihood method, the CoNS species 
were divided into three clusters (Figure 2.1): the first contained the S. epidermidis group; 
the second cluster comprised the groups of S. hominis, S. warneri, S. equorum and S. 
pettenkoferi; and the third cluster contained the groups of S. haemolyticus and S. capitis. It 
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is important to take into account that the phylogenetic relationships among CoNS species 
we derived in our study were limited, since a restricted number of different species was 
available for study. Besides, some of the rpoB sequence-based relationships we found were 
in accordance with those previously published (Drancourt and Raoult, 2002; 
Ghebremedhin et al., 2008; Hellmark et al., 2009). Of upmost importance, the relationship 
between S. capitis and S. haemolyticus, formerly regarded as incorrect by Drancourt and 
Raoult (2002), was indeed reported later by Ghebremedhin et al. (2008), and confirmed by 
our results. 
2.4. Conclusions 
The results described in this chapter show that sequence-based analysis of rpoB gene 
is a simple, rapid, and reliable method for the identification of different CoNS species. 
Moreover, the great diversity of CoNS species found in this study emphasises the need for 
studying each species as a separate entity and with its own features.  
In the following chapters, the strains isolated and described herein will be further 
characterised, namely at the level of biofilm formation and antibiotic susceptibility 
profiles. 
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Figure 2.1. Maximum likelihood tree based on partial rpoB gene sequences showing the phylogenetic 
relationships among 61 CoNS isolates representing 7 different species. The scale bar indicates the 
evolutionary distance between sequences. 
  
 
Chapter III 
Carriage of biofilm-associated genes among commensal CoNS and its 
impact on biofilm formation 
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3.1. Introduction 
The genotypic basis of CoNS biofilm formation and its complex regulation have 
been studied most extensively in S. epidermidis. On the other hand, the biofilms of a few 
other CoNS species associated with human infections, such as S. haemolyticus and S. 
hominis, have been studied to a lesser extent (Fredheim et al., 2009; Mendoza-Olazaran et 
al., 2013). With regards to S. epidermidis, several biofilm-associated factors have been 
described with different roles in the biofilm formation process (Otto, 2004; Otto, 2009) 
(Figure 3.1).  
The first step of biofilm formation, i.e. adhesion, depends on the bacterial cell 
surface characteristics and on the nature of the attachment surface (von Eiff et al., 2002). 
Several proteins such as the autolysins/ adhesins AtlE and Aae (Heilmann et al., 1997; 
Heilmann et al., 2003), and cell wall-associated adhesins that interact with host 
extracellular matrix components (also called Microbial Surface Components Recognising 
Adhesive Matrix Molecules, MSCRAMMs) have been associated with this step 
(Arrecubieta et al., 2007; Nilsson et al., 1998; Williams et al., 2002). In the following step, 
i.e. accumulation, the production of an extracellular matrix mainly composed by 
 
Figure 3.1. Schematic model of the phases involved in S. epidermidis biofilm formation on medical devices. 
Adapted from Lancet Infect Dis 2002; 2(11):677-85. 
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polysaccharides, proteins and nucleic acids occurs. This polymeric matrix plays a crucial 
role in the stabilisation of the biofilm architecture. One of the first described factors 
mediating biofilm accumulation in staphylococci was the polysaccharide intercellular 
adhesin (PIA), also known as poly-N-acetilglucosamine (PNAG), which is synthesised by 
icaADBC operon-encoded proteins (Maira-Litran et al., 2002; Rohde et al., 2007; Ziebuhr 
et al., 1997). Although the icaADBC gene is frequently found in clinically significant 
CoNS isolates, some studies have demonstrated that biofilm formation can also occur in 
ica-negative isolates (Dice et al., 2009; Esteban et al., 2010; Qin et al., 2007). These data 
have suggested the existence of PIA-independent mechanisms of biofilm accumulation. 
Since then, other factors mediating intercellular adhesion and biofilm accumulation were 
identified such as the accumulation-associated protein (Aap) (Rohde et al., 2005) and the 
Bap homologue protein (Bhp) (Tormo et al., 2005). The last step of biofilm formation is 
the less well characterised. It is thought that biofilm dispersal is controlled by the major 
quorum sensing system, agr, which controls a range of PSMs and proteases (Vuong et al., 
2004; Yao et al., 2005). 
3.1.1. Role of PIA, Aap and Bhp in biofilm formation 
PIA is a partially de-acetylated β1-6-linked N-acetylglucosamine (GlcNAc) 
homopolymer that surrounds and connects staphylococcal cells within a biofilm (Mack et 
al., 1996). The biosynthetic operon responsible for PIA synthesis is constituted by 4 
synthetic genes, icaA, icaD, icaB and IcaC (Gerke et al., 1998; Heilmann et al., 1996), and 
an upstream negative regulator gene, icaR (Conlon et al., 2002a; Conlon et al., 2002b) 
(Figure 3.2). It is known that the membrane-located GlcNAc transferase IcaA and the 
accessory IcaD membrane protein are responsible for the synthesis of PIA chains from 
activated GlcNAc monomers (Gerke et al., 1998). The transmembrane protein IcaC has 
predicted functions in the externalisation and elongation of the growing polysaccharide 
chain (Gerke et al., 1998) After externalisation, the cell surface-located enzyme IcaB 
partially de-acetylates the GlcNAc residues, introducing positive charge into the otherwise 
neutral polymer that is essential for the binding of PIA to bacterial cell surface (Vuong et 
al., 2004). 
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 The expression of the ica operon is very complex. First, it can be regulated either 
directly at the icaA promoter or through expression of IcaR protein, and is independent of 
the quorum sensing
1
 system agr (Vuong et al., 2003). Nevertheless, another staphylococcal 
quorum sensing system called luxS is known to repress ica transcription and decrease 
biofilm formation (Xu et al., 2006). The global regulatory proteins SarA e SigB (Knobloch 
et al., 2004; Tormo et al., 2005) both up-regulate ica transcription. Another possible 
mechanism of regulation is the insertion and excision of the bacterial insertion sequence 
IS256 at various locations of the operon, which can impair the production of PIA and, 
subsequently, biofilm formation (Ziebuhr et al., 1999). 
PIA has been regarded as one of the most important molecules in biofilm formation 
(Rohde et al., 2010). In the last decade, several epidemiological studies were carried out in 
                                                 
1
 A method of cell density-dependent gene regulation in bacteria 
Figure 3.2. The polysaccharide intercellular adhesin (PIA): (a) schematic representation of the icaADBC-
encoded proteins and their function during PIA synthesis; (b) organisation of the icaADBC operon. Green 
shading represents negative charge and blue shading represents positive charge; C, carboxyl; N, amino. 
Adapted from Nat Rev Microbiol (2009), 7(8):555-67. 
Diversity and characterisation of CoNS isolated from healthy individuals 
35 
 
order to investigate the distribution of the icaADBC gene and PIA production in CoNS 
clinical isolates (Arciola et al., 2005; Bradford et al., 2006; Chokr et al., 2006; Frebourg et 
al., 2000; Rohde et al., 2007; Vandecasteele et al., 2003). Interestingly, many of these 
studies found PIA production very common among this bacterial population, highlighting 
the importance of PIA during CoNS infections. In line with this assumption, the 
contribution of PIA to the virulence of CoNS species (especially S. epidermidis) was 
investigated in several animal models of infection (Li et al., 2005; Rupp et al., 2001; Rupp 
et al., 1999a; Rupp et al., 1999b), demonstrating a link between PIA synthesis and 
virulence. At the same time, some other studies on animal models of S. epidermidis 
infections raised some questions about the general and exclusive importance of icaADBC 
and PIA for pathogenesis (Chokr et al., 2007; Francois et al., 2003). Hence, while it has 
been thought for a long time that PIA was essential for biofilm formation, it is now known 
that this process may be additionally or exclusively mediated by specific surface proteins.  
Aap is a cell wall-anchored protein encoded by the aap gene and comprises two 
major domains, A and B. Aap is known to interact with PIA, forming a protein-
polysaccharide biofilm network (Bateman et al., 2005). In fact, Aap was initially assigned 
to have a role in anchoring PIA to the bacterial cell surface (Hussain et al., 1997). 
However, Aap was later found to promote biofilm formation in a PIA-independent manner 
(Rohde et al., 2005). In S. epidermidis removal of Aap domain A leads to exposure of 
domain B, which in turn provides this protein intercellular adhesive properties essential in 
the accumulation stage of biofilm formation (Rohde et al., 2005). Interestingly, Aap also 
seems to play an essential role in the colonisation of the skin (Macintosh et al., 2009), 
which makes this protein a bifunctional molecule important for both commensal and 
pathogenic lifestyles of S. epidermidis. The regulatory mechanisms that control 
transcription of aap gene are not yet clearly understood. Nevertheless, a study on S. 
epidermidis biofilms at different developmental stages found this gene to be down-
regulated in the late stage of biofilm formation (Yao et al., 2005). This result suggested 
that Aap may play a role in the early stages of biofilm development rather than in the 
maintenance of S. epidermidis biofilms. Similarly to icaADBC, aap gene is common 
among clinical isolates (Rohde et al., 2007; Stevens et al., 2008; Vandecasteele et al., 
2003; Vuong et al., 2004). Additionally, Aap-dependent biofilm formation was also 
directly demonstrated in clinical isolates (Rohde et al., 2007; Rohde et al., 2005), 
indicating that Aap is, like PIA, an important virulence factor.  
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Besides Aap, another surface protein called Bhp is also thought to be involved in 
CoNS biofilm formation (Tormo et al., 2005). This protein is homologue to the biofilm-
associated protein (Bap) of S. aureus, which was first identified in strong biofilm-forming 
S. aureus strains from chronic bovine mastitis (Cucarella et al., 2001). It seems that Bap 
has different roles during biofilm formation, namely in primary attachment (interaction 
with abiotic surfaces and host extracellular matrix proteins) and in the step of bacterial 
accumulation, possibly in cooperation with PIA (Cucarella et al., 2001). Besides S. aureus, 
Bap is also found (usually in a small proportion) among different CoNS strains isolated 
from animal infections, although it was initially thought to be absent in human-related 
strains (Tormo et al., 2005). However, a recent study reported a small proportion of human 
S. epidermidis isolates carrying the bap gene (Potter et al., 2009). Interestingly, its 
homologue Bhp was also found to be present in human strains of S. epidermidis and, 
taking into account the sequence and protein similarities with Bap, Bhp was assumed to 
have similar functions (Tormo et al., 2005). Bhp is encoded by the bhp gene, which is 
found in approximately 10-45% of S. epidermidis isolated from human infections, 
depending on the study (Bowden et al., 2005; Rohde et al., 2007; Rohde et al., 2004). 
Therefore, the significance of Bhp for S. epidermidis and other CoNS biofilm formation 
and pathogenesis remains to be determined.  
In summary, it becomes clear that different molecules are involved in CoNS biofilm 
formation, with both proteins and polysaccharides having similar importance (Schommer 
et al., 2011). 
3.1.2. CoNS: a life between commensalism and pathogenicity 
The ubiquitous nature of CoNS, as commensal microorganisms of the skin and 
mucous membranes, makes the differentiation between clinical significant (invasive) and 
commensal (contaminating) isolates a difficult task. Thus, a reliable method to correctly 
identify invasive isolates is vital to clinical decision making (Gu et al., 2005). Biofilm 
phenotype has been appointed as a marker to differentiate invasive from commensal 
isolates, though results are not very consistent (Cho et al., 2002; de Silva et al., 2002; 
Galdbart et al., 2000; Jain and Agarwal, 2009; Nayak et al., 2011; Vogel et al., 2000; 
Ziebuhr et al., 1997). These controversial results are mainly due to the lack of a 
standardised assay for evaluation of biofilm formation, environmental factors and 
phenotypic variation of biofilm formation (Fitzpatrick et al., 2002; Gu et al., 2005). 
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Furthermore, genes that influence biofilm formation have also been studied as molecular 
markers for invasive CoNS isolates (e.g. atlE, ica, aap and bhp) (Frebourg et al., 2000; 
Galdbart et al., 2000; Pei et al., 1999; Vandecasteele et al., 2003; Zhang et al., 2003). The 
ica gene locus is by far the most investigated in this area, and was previously suggested as 
a molecular marker of pathogenic isolates (Arciola et al., 2002; Frebourg et al., 2000). 
Nevertheless, some studies have revealed a relatively high prevalence of ica gene among 
commensal isolates (Frebourg et al., 2000; Koskela et al., 2009; Rohde et al., 2004; 
Vandecasteele et al., 2003). Consequently, this fact may leads to a low specificity when the 
presence of this gene is used to differentiate pathogenic from commensal isolates 
(Vandecasteele et al., 2003).  
As previously discussed in Chapter I, most virulence factors of CoNS also play 
important roles in the commensal lifestyle of these species. Therefore, it is now 
hypothesised that these so called virulence factors are in fact essential mechanisms for skin 
colonisation, and CoNS are merely “accidental pathogens” that use the “weapons” they 
possess to defend themselves from the host immune effectors (Otto, 2009). 
3.1.3. Aims 
To clarify the hypothesis stated above, we studied the biofilm formation ability in a 
population of CoNS isolated from healthy individuals. In addition, we analysed the 
relationship between biofilm formation and the detection of icaA, aap and bhp genes in S. 
epidermidis isolates in order to assign the contribution of each gene in this process.  
3.2. Materials and methods 
3.2.1. Bacterial isolates 
The group of 61 CoNS previously isolated (Chapter II) were tested for biofilm 
formation. The 31 isolates belonging to S. epidermidis species were additionally screened 
for the presence of the biofilm-associated genes icaA, aap and bhp.  
3.2.2. Quantification of biofilm formation 
Quantitative determination of biofilm formation was performed by using a 
microtiter-plate assay as previously described (Stepanovic et al., 2007), with some 
modifications. Briefly, bacteria were inoculated into tryptic soy broth (TSB, Liofilchem, 
Teramo, Italy) and incubated overnight at 37°C with shaking at 120 rpm. Overnight 
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cultures were adjusted to an optical density (OD) at 640 nm of 0.3 (approximately 2 x 10
8 
CFU/ml) and diluted 1:100 in TSB supplemented with 0.4% (w/v) glucose (TSBg). 
Subsequently, 200 μl of each bacterial suspension were placed into a 96-well microtiter 
plate (Orange Scientific, Braine-l’Alleud, Belgium), and incubated at 37°C with shaking at 
120 rpm for 24 (±2) h. After incubation, the bacterial cells in suspension were removed 
carefully, and each well was washed twice with 200 µl of 0.9% NaCl, air dried and stained 
by crystal violet technique. In brief, 100 µl of 99.9% methanol (Fisher Scientific, Fair 
Lawn, NJ, USA) were added to each well and allowed to react for 15 minutes. Afterwards, 
methanol was removed and the plate was briefly air-dried. Next, 200 µl of 1% (v/v) crystal 
violet (Merck, Darmstadt, Germany) were added and allowed to stain for 5 minutes. Then, 
the staining solution was carefully removed, the plate was washed twice with distilled 
water, and finally 160 µl of 33% (v/v) glacial acetic acid (Fisher Scientific, Fair Lawn, NJ, 
USA) were added. Absorbance was measured at 570 nm using a microplate reader. 
S. epidermidis 9142 and its isogenic strain S. epidermidis 9142-M10 were used as 
positive and negative controls, respectively. S. epidermidis 9142 is a strong biofilm 
producer that produces PIA, and strain 9142-M10 has a transposon inserted into the ica 
locus and thus does not produce a PIA-based biofilm (Cerca et al., 2004). All isolates were 
tested in eight wells in duplicate, and these experiments were repeated as part of three to 
five independent assays. Additionally, wells with sterile TSB alone served as controls to 
check sterility and non-specific binding of media. The mean of the absorbance of non-
inoculated wells was calculated and subtracted to all test values. Finally, the results of each 
isolate were averaged. The optical density of each isolate (ODS) was compared with the 
mean absorbance of negative control (ODNC). Therefore, isolates were classified as 
follows: non-biofilm producer (ODS ≤ ONC), weak biofilm producer (ODNC < ODS ≤ 
2xODNC), moderate biofilm producer (2xODNC < ODS ≤ 4xODNC) and strong biofilm 
producer (ODS > 4xODNC). 
3.2.3. Detection of biofilm-associated genes  
DNA templates were obtained as described in Chapter II. PCR reactions were 
performed in a final volume of 10 μl according to the following conditions: 2 μl of DNA 
template, 5 μl of DyNAzyme II PCR Master Mix 2x (Finnenzymes, Thermo Scientific, 
Finland), 1 μl of primer mixture (10 μM of each forward and reverse primer) and 2 μl of 
nuclease-free water, as described before (França et al., 2012). PCR amplifications were 
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performed using the MJ Mini thermal cycler (Bio-Rad, Hercules, CA, USA). Information 
about primers and amplification conditions is shown in Table 3.1. In each PCR run, a 
positive control (S. epidermidis ATCC 35984), and a negative control (water) were also 
included. Amplified products were analysed in 1.5% agarose gel stained with Midori 
Green DNA stain (Nippon Genetics Europe GmbH, Germany). 
Table 3.1. Primers and amplification conditions for icaA, aap and bhp genes 
Target gene Oligonucleotide primers sequence (5’ to 3’) 
Amplicon 
size (bp) 
PCR conditions 
icaA 
Fw TGC ACT CAA TGA GGG AAT CA 
417 
5 min at 94 °C;  
35 cycles of  30 s at 94 °C, 30 s at 56 °C and 
45 s at 72 °C 
10 min at 72 ºC 
Rv TCA GGC ACT AAC ATC CAG CA 
aap 
Fw GCT CTC ATA ACG CCA CTT GC 
617 
Rv GGA CAG CCA CCT GGT ACA AC 
bhp 
Fw TGG ACT CGT AGC TTC GTC CT 
213 
Rv TCT GCA GAT ACC CAG ACA ACC 
bp, base pairs; Fw, forward; Rv, reverse 
3.2.4. Statistical analysis 
All statistical analyses were performed using GraphPad Prism version 6.02 (La Jolla, 
CA, USA). Chi-square or Fisher’s exact test were used to examine the relationship 
between categorical variables. A p<0.05 was considered statistically significant. 
3.3. Results and discussion 
3.3.1. Biofilm formation 
The study of biofilm formation revealed that 35 (57%) isolates were able to produce 
biofilm. Of the 61 isolates, 21 (34%) were classified as weak, 6 (10%) as moderate, and 8 
(13%) as strong biofilm producers (Table 3.2). Similar results have been reported by other 
researchers, who observed a significant number of commensal S. epidermidis isolates able 
of forming biofilm (de Araujo et al., 2006; Hellmark et al., 2013). In fact, and with the 
exception of S. epidermidis, information on the biofilm formation of other CoNS species 
has been very limited, probably due to the lack of genome information. Interestingly, all 
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CoNS species tested exhibited ability to form biofilms, in different degrees. In respect to 
this, none of the S. capitis and S. warneri isolates were able to exhibit a strong biofilm 
phenotype. Nevertheless, and taking the data together, we found no statistically significant 
difference in biofilm formation between S. epidermidis and other CoNS species (p = 0.30). 
This finding supports the idea that biofilm formation is a common feature among several 
CoNS species (and not only in S. epidermidis), and also plays an important role in an 
environment like the skin, where they are exposed to harsh conditions and extensive 
mechanical stress. Conversely, Klingenberg et al. (2005) observed that the percentage of 
biofilm formation within a group of neonatal sepsis isolates was higher among S. 
epidermidis than in other CoNS species. One possible explanation for these controversial 
findings is that this and our study focus on two distinct CoNS populations (pathogenic and 
commensal CoNS, respectively). 
Table 3.2. Biofilm formation ability among 61 commensal CoNS species from healthy individuals 
 
CoNS species  
S. 
epidermidis 
S. capitis S. homins S. warneri S. haemolyticus 
Other 
CoNS 
Total, 
number (%) 
Number (%) of 
isolates 
31  (51) 9 (15) 8 (13) 6 (10) 4 (6) 3  (5) 61 (100) 
Biofilm formation ability 
Non-biofilm 
producer  
11  (35) 5 (56) 4 (50) 4 (67) 1 (25) 1  (33) 26  (43) 
Weak biofilm 
producer  
11  (35) 3 (33) 2 (25) 2 (33) 2 (50) 1  (33) 21  (34) 
Moderate 
biofilm 
producer 
5   (16) 1 (11) 0 (0) 0 (0) 0 (0) 0 (0) 6  (10) 
Strong biofilm 
producer 
4   (13) 0 (0) 2 (25) 0 (0) 1 (25) 1  (33) 8   (13) 
3.3.2. Detection of icaA, aap and bhp genes and its relationship with biofilm formation 
Due to the lack of genome information regarding to other CoNS species, we decided 
to investigate the presence of icaA, aap and bhp only in S. epidermidis isolates. Of the 31 
S. epidermidis isolates, 12 (39%) were positive for icaA, 18 (58%) for aap, and 6 (19%) for 
bhp. The same primers were also used to evaluate whether amplification would occur from 
DNA isolated from some isolates belonging to the six other CoNS species found in this 
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study. However, no products were obtained, thus it was considered these sets of primers 
were not suitable for the screening of these genes in non-S. epidermidis species. This could 
be partially explained by the fact that primer design was only based on the sequences of the 
S. epidermidis published genomes.  
The majority of the S. epidermidis isolates (23, 74%) were positive for at least 1 of 
the 3 genes, and only 8 isolates (26%) were negative for all 3 genes. A great proportion of 
isolates (n = 12, 39%) exhibited only one of the three genes. Nevertheless, 11 isolates 
(35%) had at least 2 genes, 9 of those isolates (29%) had a 2-gene combination, and 2 
isolates (6%) had all 3 genes. The combination most frequently observed was icaA-aap 
(n = 8, 26%).  
Other studies that addressed the distribution of these genes (except bhp), among 
commensal S. epidermidis isolates, also reported very similar results (de Araujo et al., 
2006; Hellmark et al., 2013). The high rate of isolates carrying the aap gene suggests that 
Aap is of extreme importance in the commensal stage of this bacterium. Recently, 
Macintosh et al. (2009) found that this protein can promote adhesion to corneocytes (dead 
cells present in the outermost layer of the human epidermis) and is likely to be an 
important adhesin in S. epidermidis skin colonisation. Additionally, intercellular adhesion 
provided by PIA and biofilm-related proteins is assumed to be crucial in an ecological 
niche like the skin (Otto, 2009). On the other hand, Rogers et al. (2008) suggested that the 
presence of icaADBC is detrimental to the colonisation of human skin by S. epidermidis, 
which may partially explain why the carriage rate of icaA is lower than that observed for 
the aap gene in our population. Finally, only a minority of isolates was found to carry the 
bhp gene, a result already reported by Rohde et al. (Rohde et al., 2004), which suggest a 
less important role of Bhp in the commensal lifestyle of S. epidermidis. 
Analysing the distribution of each gene, we observed that icaA and aap were more 
frequently detected among biofilm formers comparatively to non-biofilm former isolates 
(Figure 3.3). Nevertheless, a small fraction of non-biofilm formers also carried icaA or aap 
genes. Regulation of these two genes appears to be extremely complex and not completely 
understood, as described above (Arciola et al., 2004; Bowden et al., 2005; Conlon et al., 
2002a; Fitzpatrick et al., 2002; Yao et al., 2005; Ziebuhr et al., 1997), and may be 
involved in S. epidermidis phase-variation which appears to improve bacterial survival and 
growth under changing environmental conditions in vivo (Ziebuhr et al., 1999). Therefore, 
down-regulation of the expression of icaA and aap genes might be responsible for the 
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observed biofilm-negative phenotype in those isolates. These findings emphasise the 
complexity associated with the biofilm structure and its expression. 
 
Figure 3.3. Distribution of icaA, aap and bhp genes between biofilm and non-biofilm formers;  
* statistically significant difference (p < 0.05). 
On the other hand, the bhp gene was equally distributed between biofilm and non-
biofilm formers. In fact, the assumption that Bhp could be involved in biofilm 
accumulation was based solely on its remarkable structural similarity with Bap from S. 
aureus (Tormo et al., 2005), but no experimental evidence to support this hypothesis has 
been obtained to date. The few studies on this matter have reported inconsistent results on 
the distribution of the bhp gene among S. epidermidis isolates from human infections 
(Bowden et al., 2005; Rohde et al., 2007; Rohde et al., 2004), which have hindered the 
elucidation of the role of this protein in biofilm formation. Although only a minority of 
isolates analysed in this study carried the bhp gene, we observed that the presence of this 
gene is associated with moderate/ strong biofilm formation only in the cases in which icaA 
or icaA+aap were also detected. Most importantly, our results represent a little step 
forward in the elucidation of Bhp in S. epidermidis biofilm formation, and challenge the 
hypothesis that this protein plays a significant role in the accumulation stage of this 
process.   
Interestingly, in 4 isolates classified as weak-biofilm producers, none of the 3 genes 
was detected (Figure 3.4). These isolates may suggest divergence at the primer binding site 
(false negative PCR result) or represent a distinct mechanism of biofilm formation 
independent of ica, aap or bhp. A similar study on commensal S. epidermidis isolates from 
healthy individuals (de Araujo et al., 2006) also reported a biofilm-producing isolate that 
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lacked both icaA and aap genes, although the presence of the bhp gene was not 
investigated. Recently, attention has been given to the extracellular matrix binding protein 
(Embp). Previously found to mediate binding to fibronectin (Williams et al., 2002), Embp 
was recently demonstrated to be sufficient for biofilm formation in icaADBC- and aap-
negative S. epidermidis isolates (Christner et al., 2010; Linnes et al., 2013)  Thus, it would 
be interesting to investigate the presence of embp gene in those isolates. 
It is noteworthy that all isolates exhibiting a strong biofilm (100%), and 60% with a 
moderate biofilm phenotype harboured at least two of the three genes studies. On the other 
hand, only 36% of the weak biofilm-producers carried two genes (icaA and aap). The 
statistical analysis demonstrated a significant association (p = 0.03) between the detection 
of these genes and biofilm formation, indicating a strong correlation between strong 
biofilm formation and the simultaneous presence of two or three biofilm-associated genes 
(Figure 3.4).  
Another important finding is that all isolates in which the bhp gene was detected 
alone (3, 10%) no biofilm formation was observed. This finding put in question again the 
role of Bhp in biofilm formation, and suggests that this protein alone may not be able to 
form a mature, multilayered biofilm. Nevertheless, it would be interesting to assess 
whether this gene is being expressed or not in such isolates. In contrast, some isolates in 
 
Figure 3.4. Association between the detection of icaA, aap and bhp genes and biofilm formation in 31 
commensal S. epidermidis isolates obtained from healthy individuals. 
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which only aap gene was detected were able to produce biofilm, including moderate 
biofilm formation.  
Overall, our observations emphasise the importance of these genes, especially ica 
and aap, in S. epidermidis biofilm formation. In addition, the data obtained here suggest 
that the simultaneous presence of two or three of the genes studied has an important impact 
in the biofilm formation, highlighting the real complexity of this highly regulated process.  
3.4. Conclusions 
In conclusion, this study provides evidence that biofilm formation ability is a 
transversal feature among commensal, community-associated CoNS, and not exclusive of 
clinical isolates causing infection as some authors have argued (Galdbart et al., 2000; 
Ziebuhr et al., 1997). Our results provide evidence that biofilm formation and biofilm-
related factors also have an important role in the commensal lifestyle of these 
microorganisms, and may partially explain why CoNS are becoming important nosocomial 
pathogens, despite their lack of recognised virulence factors other than biofilm formation. 
Additionally, our experiments addressed the contribution of some biofilm-related 
factors in biofilm formation, confirming the extreme importance of PIA and Aap, and 
raising some questions about the real importance of Bhp in this process. 
 
  
 
Chapter IV 
Antibiotic resistance among community-associated CoNS and association 
with biofilm formation 
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4.1. Introduction 
Currently, there are a wide range of antibiotics that can be used in the treatment of 
staphylococcal infections. Some of them are naturally found substances (e.g. penicillin), 
while others are synthetically developed (e.g. ciprofloxacin). Nevertheless, staphylococci, 
and CoNS in a particular manner, have been recognised by their striking ability to rapidly 
developing resistance to antibiotics (Lentino et al., 2008).  
The key for the successful establishment of staphylococci as nosocomial pathogens 
comes partially from their extraordinary ability to deal with selective pressures, as well as 
developing or acquiring antibiotic resistance (Schoenfelder et al., 2010). One of the most 
representative examples of this situation is the case of the β-lactam antibiotics. Penicillin, 
introduced in the 1940s, was the first effective and non-toxic antibiotic with activity 
against staphylococcal infections. However, and only a few years later, penicillin-resistant 
strains emerged, a resistance due to the production of an enzyme called β-lactamase 
(Livermore, 2000). As a result, a β-lactamase stable penicillin called methicillin was 
introduced in 1960. Unexpectedly, resistance to this antibiotic took no more than two years 
to emerge (Enright et al., 2002).  
Similar developments have occurred for almost all the other classes of antibiotics 
(see table 4.1), which have drastically reduced the treatment options for staphylococcal 
infections (Livermore, 2000). Glycopeptides, particularly vancomycin, are currently 
regarded as one of the last resorts for the treatment of infections caused by methicillin-
resistant S. aureus and CoNS. Nevertheless, an increasing number of studies reporting both 
decreased susceptibility and resistance to vancomycin among staphylococcal clinical 
isolates, (Center et al., 2003; Dunne et al., 2001; Garrett et al., 1999; Juarez-Verdayes et 
al., 2006; Nunes et al., 2006; Pina et al., 2000; Schwalbe et al., 1987) has evidenced a 
serious threat to the efficacy of this antibiotic in a near future. 
However, it must be noted that antibiotic resistance is not an exclusive feature of 
invasive, clinically significant isolates. In fact, most surveys on staphylococcal antibiotic 
resistance have focused on this group of isolates (Claesson et al., 2007; Ghadiri et al., 
2012; Monsen et al., 2005; Sharma et al., 2010), but when it comes to the prevalence of 
resistance among staphylococcal commensal flora from healthy population, we only find
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Table 4.1. Classes of antibiotics with activity against staphylococci, and their respective mechanisms of action and resistance (Fluit et al., 2001) 
Class Main antibiotics Mechanism of action Mechanisms of resistance 
β-lactams 
Penicillins 
Methicillin1 
Oxacillin 
Amoxicillin 
Interference with the synthesis of the bacterial cell wall: 
β-lactam antibiotics bind to specific target enzymes called penicillin-binding 
proteins (PBPs) that are essential for cell wall peptidoglycan synthesis 
Inactivation of the antibiotic molecule by enzymatic hydrolysis of the β-lactam ring 
(β-lactamase production) 
Acquisition of the mecA gene that encodes an alternative penicillin-binding protein 
(PBP2a) with low affinity for most β-lactam antibiotics 
Glycopeptides Vancomycin Interference with the synthesis of the bacterial cell wall 
Acquired genetic resistance involving the vanA gene 
Thickness of the bacterial cell wall (less understood mechanism) 
Fluoroquinolones Ciprofloxacin 
Interference with the bacterial DNA replication: 
inhibition of the enzymes DNA gyrase and topoisomerase IV, which are 
involved in the folding and supercoiling of the DNA after replication 
Mutational alterations in the target genes 
Over expression of efflux pumps 
Aminoglycosides Gentamicin 
Inhibition of protein synthesis by binding to the bacterial 30S ribosomal 
subunit 
Inactivation of the antibiotic molecule by aminoglycoside-modifying enzymes 
Mutational alterations in the target genes 
Macrolides Erythromycin 
Inhibition of protein synthesis by binding to the bacterial ribosomal 50S 
subunit 
Mutational alterations in the target genes 
Rifamycins Rifampicin 
Inhibition of protein synthesis by binding to the 
β-subunit of the RNA polymerase (encoded by the rpoB gene) 
Mutational alterations in the target genes (mainly point mutations - single 
nucleotide polymorphism (SNP) - in the rpoB gene 
1Methicillin is no longer in clinical use 
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a residual number of published studies (Begovic et al., 2013; de Araujo et al., 2006; 
Dominguez et al., 2002). Additionally, it is important to take into account that human 
indigenous commensal flora is also exposed to some selective pressures, including those 
from antibiotic use, that it may act as a reservoir of resistance determinants (Marshall et 
al., 2009). Hence, a larger number of studies on commensal bacteria are required in order 
to assess their role in the development and spread of antibiotic resistance. 
4.1.1. Aims 
Since commensal bacteria are now regarded as a reservoir for antibiotic resistance 
determinants, the main aim of the work described in this chapter was to investigate the 
frequency of antibiotic resistance among commensal, community-associated CoNS isolates 
obtained from Portuguese healthy individuals. According to the questionnaire data, we also 
attempted to determine whether there is medical and/ social factors that could affect 
colonisation by antibiotic-resistant isolates. 
In addition, we aimed to correlate antibiotic resistance with biofilm formation, as 
well as with the presence of biofilm-associated genes (data previously described in Chapter 
III) in order to provide new insights into this controversial issue.  
4.2. Materials and methods 
4.2.1. Bacterial isolates 
The group of 61 CoNS previously isolated (Chapter II) was tested for antibiotic 
susceptibility. 
4.2.2. Assessment of antibiotic susceptibility profiles 
Antibiotic susceptibility was tested using the broth microdilution method according 
to the recommendations of the European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) (EUCAST-ESCMID, 2003). The following antibiotics and dilution 
ranges (in μg.ml-1) were tested: ciprofloxacin (CIP, 0.125-8), erythromycin (ERY, 0.125-
8), gentamicin (GEN, 0.125-8), penicillin (PEN, 0.125-8), rifampicin (RIF, 0.015-2), and 
vancomycin (VAN, 0.125-8) (Sigma-Aldrich, USA). 
Before performing the antibiotic susceptibility assay, several dilutions of each 
antibiotic in TSB were prepared. Every well was inoculated with 95 µl of TSB 
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supplemented with antibiotic plus 5 μl of an overnight culture previously diluted 1:100 in 
0.9% NaCl. This procedure led to a final bacterial concentration in each well of 
approximately 5 x 10
5
 CFU/ml as assessed by CFU plating (Appendix D). The plates were 
incubated at 37°C for 16-20 h (24h for vancomycin) and in the following day the wells 
were analysed in terms of presence or absence of cell growth. The minimum inhibitory 
concentration (MIC) was determined as the lowest concentration of an antibiotic that 
inhibited the visible growth of a microorganism. Each isolate was tested at least in two 
independent occasions in duplicate. Staphylococcus aureus ATCC 29213 was used as a 
control strain. All isolates were classified into susceptible, intermediate, or resistant based 
in the most recent MIC breakpoints for Staphylococcus spp. established by EUCAST 
(EUCAST, 2013). Multidrug resistance was defined as resistance to three or more classes 
of the antimicrobial agents tested. 
4.2.3. Statistical analysis 
All statistical analyses were performed using GraphPad Prism version 6.02 (La Jolla, 
CA, USA). The differences in the distribution of antibiotic resistant isolates were analysed 
by Chi-square or Fisher’s exact test. A p<0.05 was considered statistically significant.  
4.3. Results and discussion 
4.3.1. Overall antibiotic resistance 
The results of antimicrobial susceptibility are summarised in Table 4.2. The highest 
rates of resistance were detected for erythromycin (n = 27, 44%), penicillin (n = 23, 38%) 
and gentamicin (n = 15, 25%) while the lowest rate was exhibited for ciprofloxacin (n = 4, 
7%). All isolates were susceptible to rifampicin and vancomycin. Overall, 75% (n = 46) of 
the isolates were resistant to at least one class of antibiotics tested, and 39% (n = 24) 
exhibited resistance towards more than one antimicrobial class. Multidrug resistance was 
observed in 15% (n = 9) of CoNS isolates. Interestingly, the frequency of resistance for 
gentamicin and penicillin was significantly higher in S. epidermidis than in other CoNS. 
Antibiotic resistance is a multifactorial phenomenon, and high rates of antibiotic 
consumption, along with their misuse, are pivotal factors that have created this serious 
public health issue (Steinke and Davey, 2001). Moreover, it is currently known that 
antibiotic molecules are widely disseminated in a broad range of environmental sources 
(Martinez, 2009). Hence, their presence in different ecological niches may also account for
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Table 4.2. Antimicrobial resistance profiles to six antimicrobial agents (μg.ml-1) in 61 CoNS isolates isolated from the skin of healthy individuals 
Antimicrobial agent 
S. epidermidis (n = 31) Others CoNS
2
 (n = 30) 
Overall % resistance
1
 (n = 61) p-value
3 
MIC range % Resistance
1 
MIC range % Resistance
1 
Ciprofloxacin 0.25 - 8 6 ≤0.125 – 2 7 7 1.000 
Erythromycin ≤0.125 - >8 48 ≤0.125 - >8 40 44 0.610 
Gentamicin 0.25 - 2 42 ≤0.125 – 2 7 25 0.002* 
Penicillin ≤0.125 - >8 52 ≤0.125 - >8 23 38 0.030* 
Rifampicin ≤0.015 - 0.03 0 ≤0.015 - 0.06 0 0 n/a 
Vancomycin 1 - 4 0 ≤0.125 – 4 0 0 n/a 
1
 isolates classified as intermediate-resistant are included here 
2 
S. capitis, n = 9; S. hominis, n = 8; S. warneri, n = 6; S. haemolyticus, n = 4; S. equorum, n = 2; S.  pettenkoferi, n = 1 
3 Fisher’s exact test 
* Statistically significant difference 
n/a - not applicable 
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the local selection of resistant bacteria. Recent data from a European surveillance program 
(EUCAST, 2013) reported that Portugal was one of the countries with higher rates of 
antibiotic consumption outside hospitals. Penicillins and macrolides were the most 
prescribed drugs in the last years, which may partially explain the high levels of resistance 
for these classes of antibiotics found in our study. In contrast to the very few studies on 
CoNS isolated from healthy individuals (Cove et al., 1990; Widerstrom et al., 2011), we 
observed a higher resistance rate to gentamicin.  
It is also noteworthy that a considerable proportion of isolates (n = 42, 69%) 
exhibited a decreased susceptibility to vancomycin (MIC ≥ 2 μg.ml-1). Of these isolates, 
71% (n = 30) were S. epidermidis. Although resistance to vancomycin has not become 
widespread to date, some researchers have reported increasing vancomycin MICs both in 
clinical (Center et al., 2003; Garrett et al., 1999; Pina et al., 2000) and in commensal 
(Palazzo et al., 2005) staphylococcal isolates. 
Additionally, we found no significant statistic difference in the distribution of 
resistant isolates among the different groups of subjects (Table 4.3). Most importantly, it 
appears that the frequency of resistance to individual antibiotics does not seem to be 
affected by the use of antibiotics in the community. Nevertheless, one cannot neglect the 
effect of the increased antibiotic use in the accumulation of antibiotic-resistance 
determinants.  
In general, these are worrisome results since it appears that resistance and/ or 
decreased susceptibility to currently available drugs for most staphylococcal infections are 
not confined to the hospital settings but are also becoming spread in the community. 
Moreover, the widespread of multiresistant CoNS observed among our study population, 
colonising even subjects without contact with hospital environment and/ or antibiotic use 
in recent past, is also a matter of concern. However, the origin of such resistance remains 
unclear. 
4.3.2. Association between antibiotic resistance and biofilm formation 
In an attempt to identify whether there is a relationship between antibiotic resistance 
and biofilm formation, we performed a comparison between the data obtained on antibiotic 
susceptibility assays and the data obtained on biofilm formation (previously described in 
Chapter III). 
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Table 4.3. Distribution of resistant isolates among the 59 healthy individuals 
Characteristic 
Colonised with antibiotic resistant isolate 
Relative risk (95% CI1) p-value
2 
Yes (n = 40) No (n = 19) 
Socio-demographic characteristics 
Age (years)    0.2753 
0-18 6 2   
19-30 19 14   
31-50 8 2   
51-79 7 1   
Gender    1.000 
Male 20 9   
Female 20 10   
Medical characteristics 
Hospitalisation in the last year 6 1 1.311 (0.9133 - 1.882) 0.411 
Antibiotic use in the last year 13 2 1.412 (1.039 - 1.920) 0.101 
Contact with medical staff/ 
medical care employee 
15 7 1.036 (0.7186 - 1.495) 1.000 
On medication 13 2 1.412 (1.039 - 1.920) 0.101 
Allergic diseases 10 2 1.306 (0.9365 - 1.820) 0.303 
Daily habits 
Hand washing with frequency 39 19 0.6724 (0,5618 - 0.8048) 1.000 
Shower everyday 32 17 0.8163 (0.5632 - 1.183) 0.476 
Smoker/ exposure to tobacco 
smoke 
15 7 1.036 (0.7186 - 1.495) 1.000 
Tattoos/ acupuncture in the last 
year 
1 1 0.7308 (0.1807 - 0.2956) 0.544 
Gym/ pool/ sauna users 15 5 1.170 (0.8284 - 1.653) 0.558 
1Confidence interval; 2Fisher’s exact test; 3Chi-square test 
From this analysis, we observed that the frequency of antibiotic resistance was 
always higher in biofilm formers than in non-biofilm formers for all antibiotics, with 
exception for ciprofloxacin (Figure 4.1). This analysis did not include rifampicin and 
vancomycin since no resistance was observed for these two antibiotics. In general, we also 
found a significant higher frequency of antibiotic resistance in biofilm formers than in non-
biofilm formers (p = 0.02) (Figure 4.1). Moreover, we also found a significant higher 
proportion of multidrug-resistant isolates among biofilm formers comparing with non-
biofilm formers (p = 0.03). Overall, our findings demonstrate a clear tendency of isolates 
with biofilm formation ability to be resistant to two or more antibiotics simultaneously.   
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In order to elucidate the nature of the relationship between antibiotic resistance and 
biofilm formation, we also compared the data obtained on antibiotic susceptibility assays 
with the detection of icaA and aap genes. However, and in this particular case, the analysis 
was limited to 31 isolates, since the presence of such genes was only assessed for S. 
epidermidis isolates, as discussed in the previous chapter. 
In general, we also observed a tendency of isolates that carry the icaA and/ or aap 
genes to be resistant to two or more antibiotics simultaneously (Figure 4.2). However this 
association was not statistically significant, perhaps due to the reduced sample size.  
Interestingly, and when analysing the frequency of resistance for each of the 
antibiotics tested, the results were slightly different. It may be noticed that, even though 
generally present, the association between the presence of icaA gene and antibiotic 
resistance was particularly evident for gentamicin, with a p-value much close to the 
significance level (p = 0.07) (Figure 4.3). However, and with regards to aap gene, the same 
association was not observed. In this case, only resistance to ciprofloxacin and gentamicin 
was more frequent among aap+ isolates, although no statistically significant differences 
were found. 
The association between antibiotic resistance and biofilm formation in staphylococci 
is not recent and not even a consensual concept. While some researchers did not find such 
 
 Figure 4.1. Association between antibiotic resistance and biofilm formation in 61 CoNS isolates from 
healthy individuals. * represents a statistically significant difference (p<0.05); CIP, ciprofloxacin; ERY, 
erythromycin; GEN, gentamicin; PEN, penicillin; R represents the number of antibiotics to which the 
isolates were found to be resistant. 
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association (Kotilainen et al., 1991), several others have been reported it in both clinical 
(Arciola et al., 2005; Montanaro et al., 2007) and commensal CoNS isolates (Agarwal and 
Jain, 2012; de Araujo et al., 2006).  
  
Figure 4.2. Association between antibiotic resistance and detection of biofilm-associated genes in 31 S. 
epidermidis isolates from healthy individuals. R represents the number of antibiotics to which the isolates 
were found to be resistant. 
 
 
Figure 4.3. Association between resistance and detection of biofilm-associated genes for each antibiotic 
tested in 31 S. epidermidis isolates from healthy individuals; CIP, ciprofloxacin; ERY, erythromycin; GEN, 
gentamicin; PEN, penicillin.  
The two important questions that remain to be elucidated on this matter is the nature 
of such association and if it is observed in different classes of antibiotics. Overall, our 
findings in commensal isolates from healthy individuals support the existence of an 
association between antibiotic resistance and biofilm formation. Most importantly, this 
association was more pronounced for gentamicin, a finding also previously reported in 
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clinical S. epidermidis isolates (Kozitskaya et al., 2004; Montanaro et al., 2007). Some 
authors have suggested that this association could be mediated by the presence of 
transposons (Kozitskaya et al., 2004; Ziebuhr et al., 2000). It is currently known that 
antibiotic resistance genes are often associated with these mobile genetic elements, and 
some of them are flanked by insertion sequences, such as IS256. Tn4001, a transposon 
carrying a gene that confers resistance to a wide range of aminoglycosides, including 
gentamicin (Culebras and Martinez, 1999), is usually flanked by the IS256 (Kozitskaya et 
al., 2004). On the other hand, the association of IS256 with biofilm formation, and 
specifically with the icaADBC operon, is well documented, as was already discussed in 
Chapter III. This may in turn explain the association we observed between carriage of icaA 
gene and resistance to the different antibiotics tested, and why the same association was 
not observed for aap gene.  
It is tempting to conclude from our results that this association might be restricted to 
some classes of antibiotics, especially aminoglycosides, and that it may be primarily 
associated with icaADBC operon and not with the biofilm phenotype per se. However, and 
in order to prove this hypothesis, further investigations with a much larger number of 
isolates as well as antibiotic classes is mandatory.  
4.4. Conclusions 
In general, we concluded that the rate of antibiotic resistance in CoNS isolated from 
the skin of healthy individuals in Portugal is relatively high, providing evidence that 
resistant CoNS strains are indeed disseminated in the community, supporting the 
hypothesis that staphylococcal skin flora represents a reservoir of potentially pathogenic 
bacteria. Moreover, the reduced susceptibility of these microorganisms to commonly used 
antibiotics might promote their persistence in the healthy community and long-term 
colonisation. Then, and most important of all, our results emphasise the urgency in the 
establishment of more strict policies regarding to antibiotic consumption since the 
availability and misuse of antibiotics appear to select and/or maintain antibiotic-resistance, 
even in healthy, non-treated individuals. Additionally, multidrug-resistance is one of the 
most feared aspects of antibiotic resistance and an increasing challenge for medical 
community. Hence, the development of novel anti-staphylococcal agents is of paramount 
importance.  
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On the other hand, our results enabled us to observe a clear association between 
antibiotic resistance and biofilm formation. To our knowledge, this is the first study on 
community-associated CoNS isolates (and not only S. epidermidis), reporting such 
association. Nevertheless, and taking into account the results of other studies, our findings 
lead us to challenge the hypothesis that this association is common throughout all 
antibiotic classes. We rather hypothesise that this association is confined to some classes of 
antibiotics and is primarily associated with the presence of the icaADBC operon. 
 
  
 
Chapter V 
Expression of icaA and aap at different stages of S. epidermidis biofilm 
development 
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5.1. Introduction 
Biofilm formation is a complex process that seems to be controlled by several 
factors. In the last decade, several research groups have been focused on the molecular 
mechanisms behind biofilm formation, aiming to identify different gene expression 
patterns in different bacterial species, and at different biofilm developmental stages (Beloin 
and Ghigo, 2005). 
Essentially, genetic analyses have revealed a wide range of genetic determinants 
involved in biofilm formation but, most importantly, they have uncovered the concept that 
there are multiple pathways to form a biofilm (O'Toole, 2003). In contrast, several studies 
have reported that only a small proportion of the bacterial genome undergoes a significant 
change in expression when bacteria shift from a planktonic, free-floating, to a biofilm 
mode of growth (Ren et al., 2004; Stanley et al., 2003; Whiteley et al., 2001).  
With regards to S. epidermidis, there is also a broad knowledge on the molecular 
basis of biofilm formation. The function of important biofilm-associated genes, such as 
icaADBC and aap, in the mediation of the accumulative phase of biofilm development was 
already established, as described throughout Chapter III. However, studies that follow gene 
expression from early to late stages of biofilm formation are lacking. Hence, it is not 
currently know the specific contribution of each biofilm-associated gene in distinct phases 
of S. epidermidis biofilm development.  
5.1.1. Aims 
The aim of this study was to determine whether two important S. epidermidis 
biofilm-associated genes, icaA and aap, are differentially expressed at two distinct biofilm 
developmental stages. For this purpose, gene expression levels of S. epidermidis biofilms 
grown in vitro were assessed at early (12h) and mature (54h) phases of biofilm growth.   
5.2. Materials and methods 
5.2.1. Bacterial isolates 
Two well-characterised (in Chapters III and IV) biofilm-forming S. epidermidis 
isolates from healthy individuals were used in this work: 004A (moderate-biofilm 
producer, icaA+, aap+, and bhp-) and 023A (weak-biofilm producer, icaA-, aap+, and  
bhp-). 
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5.2.2. Biofilm formation 
Biofilms were grown as previously described (França et al., 2012). Briefly, bacteria 
was inoculated into TSB and incubated overnight at 37°C with shaking at 120 rpm. 
Overnight cultures were adjusted to an OD640 of 0.3 (approximately 2 x 10
8 
CFU/ml) and 
diluted 1:100 in fresh TSBg. Subsequently, 1 ml of the diluted bacterial suspension was 
placed into a 24-well microtiter plate (Orange Scientific, Braine-l’Alleud, Belgium), 
incubated at 37°C with shaking at 120 rpm, and allowed to grow for 12 or 54 h. In biofilms 
grown for 54 h, the TSBg medium containing suspended bacterial cells was removed and 
an equal volume of fresh TSBg was added every 24 h.  
5.2.3. RNA extraction 
RNA extraction from S. epidermidis biofilms was performed using a previously 
optimised protocol (França et al., 2012). This method combines chemical (phenol) and 
mechanical (glass beads) lysis of bacterial cells along with silica membrane-based RNA 
isolation (E.Z.N.A. Total RNA Kit, Omega Bio-Tek, GA, USA). Bacterial biofilms were 
thoroughly washed, suspended in 1 ml of 0.9% NaCl, and immediately placed on ice. 
Suspended biofilm cells were centrifuged at 16000 g for 10 min at 4ºC and the 
supernatants were discarded. Then, the bacterial pellets were suspended in 500 μl of TRK 
lysis buffer (provided by the kit) supplemented with 2% β-mercaptoethanol, plus 500 μl of 
90% phenol solution (Applichem, Darmstadt, Germany). The resulting mixture was 
transferred into 2 ml safe lock tubes containing 0.5 g of acid-washed 150-212 mm silica 
beads (Sigma, USA). The tubes were then placed into FastPrep cell disruptor (BIO 101, 
ThermoElectron Corporation, USA) and beat for 35 s at 6.5 m.s
-1
. The samples were 
immediately placed on ice for 5 min and the beat-beading step was repeated twice. 
Afterwards, samples were centrifuged at 16000 g for 1.5 min at 4ºC, the supernatants 
transferred into 2 ml DNase/ RNase free tubes and mixed with an equal volume of 70% 
ethanol. The samples (including any remaining precipitate) were transferred to the silica 
columns and centrifuged at 10000 g for 30 s at room temperature (RT). The flow-through 
was discarded and each column was placed into a new collection tube. To wash the 
columns, 500 μl of Wash Buffer I were added to each column and centrifuged at 10000 g 
for 30 s at RT. The flow-through was discarded and each column was placed into the same 
collection tube. After that, 500 μl of Wash Buffer II were added to each column and 
centrifuged at 10000 g for 30 s at RT. This step was repeated once more, the flow-through 
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was discarded, and the columns were placed into new collection tubes for a new 
centrifugation at 16000 g for 2 min. The collection tubes were discarded and each column 
was then placed into 1.5 ml DNase/ RNase free tubes. Lastly, RNA elution was achieved 
by adding 50 μl of DEPC-treated water into the centre of the column, incubated for 1 min 
at RT, and centrifuging at 16000 g for 2 min.  
5.2.4. DNase treatment 
Genomic DNA was digested with DNase I (Fermentas, Ontario, Canada). 2 μl of 
DNase I and 5 μl of DNase buffer were added to each RNA sample and incubated at 37ºC 
for 30 min. Then, to inactivate the DNase I activity, 5 μl of 25 mM EDTA were added to 
the mixture and incubated at 65ºC for 10 min. 
5.2.5. RNA quality determination 
The concentration and purity of the total RNA was spectrometrically determined 
using a NanoDrop 1000 (Thermo Scientific, USA). Three independent measurements of 
the same sample were performed and averaged. The absorbance ratios A260/A280 and 
A260/A230 were used as indicators of protein and polysaccharide/ phenol/ chaotropic salts 
contamination, respectively. The integrity of the total RNA was assessed by visualisation 
of the 23S/16S banding pattern. RNA samples were analysed in 1.5% agarose gel stained 
with Midori Green DNA stain (Nippon Genetics Europe GmbH, Germany). RNA was 
stored at -20ºC until further use. 
5.2.6. cDNA synthesis 
cDNA synthesis was performed using the RevertAid First Strand cDNA Synthesis kit 
(Fermentas, Ontario, Canada) following the manufacturer’s instructions. The same amount 
of total RNA (1 μg) from each sample was reverse transcribed in a 10 μl reaction volume. 
To determine the possibility of genomic DNA carry-over, control reactions were 
performed under the same conditions but lacking the reverse transcriptase enzyme (no-RT 
control). All RNA samples extracted were absent of significant genomic DNA, as 
determined by an average cycle threshold difference of 18.39 ± 3.10, equivalent to a 
maximum quantification error of 0.0003%. 
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5.2.7. Gene expression quantification 
Biofilm gene expression was determined by quantitative real-time PCR (qPCR). 
qPCR analysis was performed using 2x iQ SYBR Green Supermix (Bio-Rad, Hercules, 
CA, USA) in a 10 μl reaction volume. Each PCR reaction contained 2 μl diluted cDNA or 
no-RT control (1:200 in DEPC-treated water), 5 μl of master mix, 1 μl of primer mixture 
(10 μM of each forward and reverse primers), and 2 μl of nuclease-free water. Information 
about the primers used is listed in Table 5.1. The efficiency of each primer set was 
previously determined (França et al., 2012). qPCR runs were performed on a CFX 96 (Bio-
Rad, Hercules, CA, USA) with the following cycle parameters: 95ºC for 3 min, 49 cycles 
of 95ºC for 10 s, 56ºC for 15 s, and 72ºC for 20 s. qPCR products were analysed by 
melting curves to confirm that only the desired product was amplified. All reactions were 
run in triplicate and a no template control (nuclease-free water) for each primer pair was 
included in each run. The expression of icaA and aap was normalised to the expression of 
the housekeeping gene 16S rRNA using the 2
ΔCt 
method, where 2 stands for 100% PCR 
efficiency and ΔCt = Ct16S rRNA - Cttarget gene. 
Table 5.1. List of the primers used in qPCR experiments 
5.2.8.  Statistical analysis 
All statistical analyses were performed using GraphPad Prism version 6.02 (La Jolla, 
CA, USA). The mean normalised gene expression was compared among the different 
Target gene Oligonucleotide primers sequence (5’ to 3’) Amplicon size (bp) 
16S rRNA 
Fw GGG CTA CAC ACG TGC TAC AA 
176 
Rv GTA CAA GAC CCG GGA ACG TA 
icaA 
Fw TGC ACT CAA TGA GGG AAT CA 
134 
Rv TAA CTG CGC CTA ATT TTG GAT T 
aap 
Fw TAA CTG CGC CTA ATT TTG GAT T 
190 
Rv GCA TGC CTG CTG ATA GTT CA 
bp, base pairs; Fw, forward; Rv, reverse 
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conditions assayed by applying student’s t test. A p<0.05 was considered statistically 
significant. 
5.3. Results and discussion 
5.3.1. icaA and aap expression during biofilm development  
In order to determine the expression profile of icaA and aap genes in different stages 
of S. epidermidis biofilm formation, we analysed the gene expression levels of both genes 
in two independent biofilm-forming S. epidermidis isolates at early (12 h) and late (54 h) 
phases of growth. By comparing the expression levels, we were able to identify an up-
regulation of both genes in 54 h comparatively with 12 h biofilms (Figure 5.1). This up-
regulation was however more evident for icaA gene, in strain 004A, with an approximately 
5-fold expression increase. 
 The role of PIA, encoded by the ica locus, in intercellular adhesion and bacterial 
aggregation was already previously discussed. In vitro studies have demonstrated that S. 
epidermidis mutants lacking PIA are not able to accumulate into multilayered biofilms 
(Dobinsky et al., 2002; Mack et al., 1994). However, studies about gene expression in S. 
epidermidis during biofilm development are still scarce, which makes difficult the 
 
Figure 5.1. Variation of icaA and aap expression levels in two different developmental stages of biofilm 
formation; results are expressed as mean ± standard deviation; * represents statistically significant 
differences (p<0.05). 
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comparison of results. A study conducted by Patel et al. (Patel et al., 2012) found an 
approximately 10-fold increase in the expression of icaA gene from 12 to 48 h, with the 
largest increase in expression occurring between 12 and 24 h. In fact, we also observed the 
same trend, i.e., the expression of icaA gene increases over the time, although we have 
studied the gene expression at a later time point (54 h). Although it is well established that 
the ica locus is conserved between S. epidermidis and S. aureus (Cramton et al., 1999), 
some studies on S. aureus biofilms found an inverse trend in the expression profile of ica 
genes (Beenken et al., 2004; Resch et al., 2005). These studies found ica genes to be 
highly expressed after 8 h of growth, gradually decreasing at later growth stages (up to 48 
h). On the other hand, another study reported that ica transcription, as well as PIA 
synthesis, appear to be markedly higher in S. epidermidis than in S. aureus strains, both in 
vitro and in vivo (Fluckiger et al., 2005), which partially might explain the controversial 
results  between these two staphylococcal species. 
With regards to aap gene, and despite being more expressed at a later stage in both 
isolates, it is noteworthy that its expression was much higher at both phases in comparison 
with icaA expression. This finding may indicate that aap has a higher contribution than 
icaA at both earlier and later phases of S. epidermidis biofilm formation, at least in strain 
004A. Nevertheless, studies on more strains are mandatory to confirm this result. 
Interestingly, the aap expression level was higher in strain 004A than that observed in 
strain 023A in both growth phases, which appears to be a reasonable explanation for the 
different biofilm phenotypes exhibited by each one, i.e., moderate and weak biofilm 
formation, respectively. Similarly to PIA, the importance of Aap in biofilm formation was 
previously demonstrated (Hussain et al., 1997; Rohde et al., 2005), and our results appear 
to corroborate its function.  
5.4. Conclusions 
Overall, our findings confirm the role of PIA and Aap in the accumulative stage of 
biofilm formation, since we found both icaA and aap genes up-regulated at 54 h 
comparatively with 12 h of growth. Moreover, our results apparently indicate that icaA is 
of more importance in a later stage of biofilm formation, which might lead to a biofilm 
with a stronger architecture.   
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In order to better understand the roles of icaA and aap in biofilm accumulation, it 
would be interesting to evaluate the expression of these genes at several stages of biofilm 
development (e.g., 6, 12, 24, 48, and 60 h), as well as the quantification of biofilm 
formation, viable cells, and polysaccharide and protein concentrations at these time points.  
  
 
Chapter VI 
Main conclusions and future directions
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6.1. Main conclusions 
Research on CoNS species has been mainly focused on clinical isolates, which are 
known to be well equipped with a range of pathogenic traits, especially an exceptional 
ability to form biofilms and high resistance rates to multiple classes of antibiotics. 
However, it is not still clear whether these two determinants are also well disseminated 
among commensal, community-associated CoNS isolates. In fact, research on commensal 
bacteria in general has been scarce, perhaps because this subset of microorganisms is 
widely regarded as harmless. Nevertheless, some researchers dedicated to the study of 
commensals have hypothesised that these bacteria might be an underappreciated reservoir 
of pathogenic determinants.  
Recognising this hypothetical role of commensal bacteria, and in order to fulfil the 
lack of studies in this neglected research field, we aimed to perform a phenotypic and 
genotypic characterisation of different CoNS species isolated from healthy Portuguese 
individuals.  
The first task of this work, i.e., the isolation and identification procedures, revealed a 
great diversity of CoNS species colonising the human skin, which emphasised the need for 
studying each species as a separate entity and with its own features.  
Throughout the following tasks, a thorough characterisation of all isolates was 
performed. Our initial results provided evidence that biofilm formation ability and the 
presence of biofilm-associated genes were common features among commensal, 
community-associated CoNS. It was then hypothesised that, besides being regarded as 
virulence factors, these features might also be essential pieces in the colonising lifestyle of 
these microoganisms. Additionally, our experiments also addressed the contribution of 
some biofilm-associated genes in biofilm formation, confirming the extreme importance of 
PIA and Aap, and raising some questions about the real importance of Bhp in this process. 
With regards to antibiotic susceptibility testing, our results showed a great proportion of 
isolates with decreased susceptibility and multiple resistances to some of the current 
available drugs for most staphylococcal infections. Moreover, we observed a significant 
association between antibiotic resistance and biofilm formation, although our results led us 
to hypothesise that such association might be confined to some classes of antibiotics and 
primarily associated with the icaADBC operon. 
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In the last task, we aimed to determine the expression patterns of two biofilm-
associated genes (icaA and aap) at two distinct biofilm developmental stages. With respect 
to this, our findings corroborated the role of both genes in the accumulative stage of 
biofilm formation.  
Overall, we are able to conclude that staphylococcal skin flora might be regarded as a 
reservoir of biofilm-forming and antibiotic resistant microorganisms, or in other words, a 
reservoir of potentially pathogenic bacteria. Simultaneously, our experiments also bring to 
light new perceptions about the molecular basis of staphylococcal biofilm formation, as 
well as the nature of the association between antibiotic resistance and biofilm formation. 
6.2. Future directions 
The conclusions drawn from the work described in this thesis highlight the urgency 
in the application of more strict policies regarding to antibiotic consumption, as well as in 
the development of novel anti-staphylococcal agents. In respect to this, suitable 
alternatives to antibiotic therapy should be a priority. 
On the other hand, our findings also raised some important questions that need to be 
elucidated. Most importantly, the experiments on biofilm formation and antibiotic 
susceptibility should be reproduced in a larger number of isolates, so that our conclusions 
can acquire more significance. With regards to biofilm formation, further studies are 
required to elucidate the role of Bhp in S. epidermidis biofilm formation. Additionally, the 
presence of biofilm-associated genes in non-S. epidermidis CoNS species should be 
investigated, in order to understand whether the staphylococcal biofilm formation process 
is transversal among CoNS or each species have their own mechanism. Moreover, other 
molecules known to be involved in biofilm formation should be studied in depth, such as 
the case of Embp. Furthermore, the association between antibiotic resistance and biofilm 
formation should also be further investigated in order definitely clarify its nature.  
Lastly, it would be interesting to evaluate the expression of a wide range of genes at 
several stages of biofilm development and growth conditions, possibly by using microarray 
technology. By following this approach it would be possible to assign the specific 
contribution of each gene during biofilm formation. 
  
 
 
 
  
 
Reference list
Diversity and characterisation of CoNS isolated from healthy individuals 
70 
 
Agarwal, A. and A. Jain (2012). Association between drug resistance & production of biofilm in 
staphylococci. Indian J Med Res 135(4): 562-564. 
Arciola, C. R., L. Baldassarri and L. Montanaro (2002). In catheter infections by Staphylococcus epidermidis 
the intercellular adhesion (ica) locus is a molecular marker of the virulent slime-producing strains. J Biomed 
Mater Res 59(3): 557-562. 
Arciola, C. R., D. Campoccia, S. Gamberini, et al. (2005). Antibiotic resistance in exopolysaccharide-
forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections. Biomaterials 
26(33): 6530-6535. 
Arciola, C. R., D. Campoccia, S. Gamberini, et al. (2004). Search for the insertion element IS256 within the 
ica locus of Staphylococcus epidermidis clinical isolates collected from biomaterial-associated infections. 
Biomaterials 25(18): 4117-4125. 
Arciola, C. R., S. Gamberini, D. Campoccia, et al. (2005). A multiplex PCR method for the detection of all 
five individual genes of ica locus in Staphylococcus epidermidis. A survey on 400 clinical isolates from 
prosthesis-associated infections. J Biomed Mater Res A 75(2): 408-413. 
Arrecubieta, C., M. H. Lee, A. Macey, T. J. Foster and F. D. Lowy (2007). SdrF, a Staphylococcus 
epidermidis surface protein, binds type I collagen. J Biol Chem 282(26): 18767-18776. 
Bateman, A., M. T. Holden and C. Yeats (2005). The G5 domain: a potential N-acetylglucosamine 
recognition domain involved in biofilm formation. Bioinformatics 21(8): 1301-1303. 
Becker, K., D. Harmsen, A. Mellmann, et al. (2004). Development and evaluation of a quality-controlled 
ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J Clin 
Microbiol 42(11): 4988-4995. 
Beenken, K. E., P. M. Dunman, F. McAleese, et al. (2004). Global gene expression in Staphylococcus aureus 
biofilms. J Bacteriol 186(14): 4665-4684. 
Begovic, J., B. Jovcic, M. Papic-Obradovic, et al. (2013). Genotypic diversity and virulent factors of 
Staphylococcus epidermidis isolated from human breast milk. Microbiol Res 168(2): 77-83. 
Beigi, R. H., M. N. Austin, L. A. Meyn, M. A. Krohn and S. L. Hillier (2004). Antimicrobial resistance 
associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191(4): 1124-1129. 
Beloin, C. and J. M. Ghigo (2005). Finding gene-expression patterns in bacterial biofilms. Trends Microbiol 
13(1): 16-19. 
Bjarnsholt, T., P. O. Jensen, M. J. Fiandaca, et al. (2009). Pseudomonas aeruginosa biofilms in the 
respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44(6): 547-558. 
Blackwell, P. A., P. Kay and A. B. Boxall (2007). The dissipation and transport of veterinary antibiotics in a 
sandy loam soil. Chemosphere 67(2): 292-299. 
Blum-Menezes, D., O. J. Bratfich, M. C. Padoveze and M. L. Moretti (2009). Hospital strain colonization by 
Staphylococcus epidermidis. Braz J Med Biol Res 42(3): 294-298. 
Bowden, M. G., W. Chen, J. Singvall, et al. (2005). Identification and preliminary characterization of cell-
wall-anchored proteins of Staphylococcus epidermidis. Microbiology 151(Pt 5): 1453-1464. 
Bradford, R., R. Abdul Manan, A. J. Daley, et al. (2006). Coagulase-negative staphylococci in very-low-
birth-weight infants: inability of genetic markers to distinguish invasive strains from blood culture 
contaminants. Eur J Clin Microbiol Infect Dis 25(5): 283-290. 
Burke, J. P. (2003). Infection control - a problem for patient safety. N Engl J Med 348(7): 651-656. 
Campoccia, D., L. Montanaro, L. Visai, et al. (2010). Characterization of 26 Staphylococcus warneri isolates 
from orthopedic infections. Int J Artif Organs 33(9): 575-581. 
Cantlon, C. A., M. E. Stemper, W. R. Schwan, M. A. Hoffman and S. S. Qutaishat (2006). Significant 
pathogens isolated from surgical site infections at a community hospital in the Midwest. Am J Infect Control 
34(8): 526-529. 
CDC (1996). National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-
April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) 
System. Am J Infect Control 24(5): 380-388. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
71 
 
Center, K. J., A. C. Reboli, R. Hubler, G. L. Rodgers and S. S. Long (2003). Decreased vancomycin 
susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of 
Staphylococcus warneri. J Clin Microbiol 41(10): 4660-4665. 
Cerca, N. and K. K. Jefferson (2012). Que vantagens têm os microrganismos em formar um biofilme? 
Biofilmes - Na Saúde, no Ambiente, na Indústria. N. Cerca and F. Azevedo. Porto, Publindustria - Edições 
Técnicas. 
Cerca, N., K. K. Jefferson, R. Oliveira, G. B. Pier and J. Azeredo (2006). Comparative antibody-mediated 
phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 
74(8): 4849-4855. 
Cerca, N., S. Martins, F. Cerca, et al. (2005). Comparative assessment of antibiotic susceptibility of 
coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or 
rapid XTT colorimetry. J Antimicrob Chemother 56(2): 331-336. 
Cerca, N., G. B. Pier, M. Vilanova, R. Oliveira and J. Azeredo (2004). Influence of batch or fed-batch growth 
on Staphylococcus epidermidis biofilm formation. Lett Appl Microbiol 39(5): 420-424. 
Chaves, F., M. Garcia-Alvarez, F. Sanz, C. Alba and J. R. Otero (2005). Nosocomial spread of a 
Staphylococcus hominis subsp. novobiosepticus strain causing sepsis in a neonatal intensive care unit. J Clin 
Microbiol 43(9): 4877-4879. 
Cheung, G. Y., K. Rigby, R. Wang, et al. (2010). Staphylococcus epidermidis strategies to avoid killing by 
human neutrophils. PLoS Pathog 6(10): e1001133. 
Cho, S. H., K. Naber, J. Hacker and W. Ziebuhr (2002). Detection of the icaADBC gene cluster and biofilm 
formation in Staphylococcus epidermidis isolates from catheter-related urinary tract infections. Int J 
Antimicrob Agents 19(6): 570-575. 
Chokr, A., D. Leterme, D. Watier and S. Jabbouri (2007). Neither the presence of ica locus, nor in vitro-
biofilm formation ability is a crucial parameter for some Staphylococcus epidermidis strains to maintain an 
infection in a guinea pig tissue cage model. Microb Pathog 42(2-3): 94-97. 
Chokr, A., D. Watier, H. Eleaume, et al. (2006). Correlation between biofilm formation and production of 
polysaccharide intercellular adhesin in clinical isolates of coagulase-negative staphylococci. Int J Med 
Microbiol 296(6): 381-388. 
Christner, M., G. C. Franke, N. N. Schommer, et al. (2010). The giant extracellular matrix-binding protein of 
Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin. Mol Microbiol 
75(1): 187-207. 
Chu, V. H., C. H. Cabell, E. Abrutyn, et al. (2004). Native valve endocarditis due to coagulase-negative 
staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. 
Clin Infect Dis 39(10): 1527-1530. 
Claesson, C., A. Hallgren, M. Nilsson, et al. (2007). Susceptibility of staphylococci and enterococci to 
antimicrobial agents at different ward levels in four north European countries. Scand J Infect Dis 39(11-12): 
1002-1012. 
Cogen, A. L., K. Yamasaki, J. Muto, et al. (2010a). Staphylococcus epidermidis antimicrobial delta-toxin 
(phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. 
PLoS One 5(1): e8557. 
Cogen, A. L., K. Yamasaki, K. M. Sanchez, et al. (2010b). Selective antimicrobial action is provided by 
phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest 
Dermatol 130(1): 192-200. 
Conlon, K. M., H. Humphreys and J. P. O'Gara (2002a). icaR encodes a transcriptional repressor involved in 
environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J 
Bacteriol 184(16): 4400-4408. 
Conlon, K. M., H. Humphreys and J. P. O'Gara (2002b). Regulation of icaR gene expression in 
Staphylococcus epidermidis. FEMS Microbiol Lett 216(2): 171-177. 
Cove, J. H., E. A. Eady and W. J. Cunliffe (1990). Skin carriage of antibiotic-resistant coagulase-negative 
staphylococci in untreated subjects. J Antimicrob Chemother 25(3): 459-469. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
72 
 
Cramton, S. E., C. Gerke, N. F. Schnell, W. W. Nichols and F. Gotz (1999). The intercellular adhesion (ica) 
locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 67(10): 5427-
5433. 
Cucarella, C., C. Solano, J. Valle, et al. (2001). Bap, a Staphylococcus aureus surface protein involved in 
biofilm formation. J Bacteriol 183(9): 2888-2896. 
Culebras, E. and J. L. Martinez (1999). Aminoglycoside resistance mediated by the bifunctional enzyme 6'-
N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase. Front Biosci 4: D1-8. 
Cunha, B. A., M. D. Esrick and M. Larusso (2007). Staphylococcus hominis native mitral valve bacterial 
endocarditis (SBE) in a patient with hypertrophic obstructive cardiomyopathy. Heart Lung 36(5): 380-382. 
D'Costa, V. M., K. M. McGrann, D. W. Hughes and G. D. Wright (2006). Sampling the antibiotic resistome. 
Science 311(5759): 374-377. 
Dancer, S. J., P. Shears and D. J. Platt (1997). Isolation and characterization of coliforms from glacial ice and 
water in Canada's High Arctic. J Appl Microbiol 82(5): 597-609. 
Daughton, C. G. and T. A. Ternes (1999). Pharmaceuticals and personal care products in the environment: 
agents of subtle change? Environ Health Perspect 107 Suppl 6: 907-938. 
de Allori, M. C., M. A. Jure, C. Romero and M. E. de Castillo (2006). Antimicrobial resistance and 
production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol Pharm Bull 
29(8): 1592-1596. 
de Araujo, G. L., L. R. Coelho, C. B. de Carvalho, et al. (2006). Commensal isolates of methicillin-resistant 
Staphylococcus epidermidis are also well equipped to produce biofilm on polystyrene surfaces. J Antimicrob 
Chemother 57(5): 855-864. 
de Silva, G. D., M. Kantzanou, A. Justice, et al. (2002). The ica operon and biofilm production in coagulase-
negative staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol 
40(2): 382-388. 
Diaz-Mejia, J. J., A. Carbajal-Saucedo and C. F. Amabile-Cuevas (2002). Antibiotic resistance in oral 
commensal streptococci from healthy Mexicans and Cubans: resistance prevalence does not mirror antibiotic 
usage. FEMS Microbiol Lett 217(2): 173-176. 
Dice, B., P. Stoodley, F. Buchinsky, et al. (2009). Biofilm formation by ica-positive and ica-negative strains 
of Staphylococcus epidermidis in vitro. Biofouling 25(4): 367-375. 
Dobinsky, S., K. Bartscht and D. Mack (2002). Influence of Tn917 insertion on transcription of the icaADBC 
operon in six biofilm-negative transposon mutants of Staphylococcus epidermidis. Plasmid 47(1): 10-17. 
Dominguez, E., M. Zarazaga and C. Torres (2002). Antibiotic resistance in Staphylococcus isolates obtained 
from fecal samples of healthy children. J Clin Microbiol 40(7): 2638-2641. 
Donlan, R. M. and J. W. Costerton (2002). Biofilms: survival mechanisms of clinically relevant 
microorganisms. Clin Microbiol Rev 15(2): 167-193. 
Drancourt, M. and D. Raoult (2002). rpoB gene sequence-based identification of Staphylococcus species. J 
Clin Microbiol 40(4): 1333-1338. 
Dunne, W. M., Jr., H. Qureshi, H. Pervez and D. A. Nafziger (2001). Staphylococcus epidermidis with 
intermediate resistance to vancomycin: elusive phenotype or laboratory artifact? Clin Infect Dis 33(1): 135-
137. 
Durando, P., M. Bassetti, G. Orengo, et al. (2010). Hospital-acquired infections and leading pathogens 
detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence 
study. J Prev Med Hyg 51(2): 80-86. 
ECDC (2012). Surveillance of healthcare-associated infections in Europe, 2007. Stockholm, ECDC. 
EFSA (2008). Foodborne antimicrobial resistance as a biological hazard. The EFSA Journal 6(8): 1-87. 
Engelkirk, P. G. and J. L. Duben-Engelkirk (2008). Laboratory Diagnosis of Infectious Diseases: Essentials 
of Diagnostic Microbiology, Wolters Kluwer Health/Lippincott Williams & Wilkins. 
Enright, M. C., D. A. Robinson, G. Randle, et al. (2002). The evolutionary history of methicillin-resistant 
Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99(11): 7687-7692. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
73 
 
Esteban, J., D. Molina-Manso, I. Spiliopoulou, et al. (2010). Biofilm development by clinical isolates of 
Staphylococcus spp. from retrieved orthopedic prostheses. Acta Orthop 81(6): 674-679. 
EUCAST-ESCMID (2003). Determination of minimum inhibitory concentrations (MICs) of antibacterial 
agents by broth dilution. Clinical Microbiology and Infection 9(8): ix-xv. 
EUCAST (2013). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1. Available at 
http://www.eucast.org [Accessed 10 March 2013] 
EUCAST (2013). Surveillance of antimicrobial consumption in Europe, 2010. Stockholm. 
Euzeby, J. (2013). List of Prokaryotic names with Standing in Nomenclature - Genus Staphylococcus. 
Available at http://www.bacterio.cict.fr/s/staphylococcus.html [Acessed 31 May 2013] 
Euzeby, J. P. (1997). List of Bacterial Names with Standing in Nomenclature: a folder available on the 
Internet. Int J Syst Bacteriol 47(2): 590-592. 
Evans, D. J., D. G. Allison, M. R. Brown and P. Gilbert (1991). Susceptibility of Pseudomonas aeruginosa 
and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J Antimicrob Chemother 
27(2): 177-184. 
Faller, A. and K. H. Schleifer (1981). Modified oxidase and benzidine tests for separation of staphylococci 
from micrococci. J Clin Microbiol 13(6): 1031-1035. 
Felsenstein, J. (1989). PHYLIP - phylogeny inference package (version 3.2). Cladistics 5: 164–166. 
Fey, P. D. and M. E. Olson (2010). Current concepts in biofilm formation of Staphylococcus epidermidis. 
Future Microbiol 5(6): 917-933. 
Fitzpatrick, F., H. Humphreys, E. Smyth, C. A. Kennedy and J. P. O'Gara (2002). Environmental regulation 
of biofilm formation in intensive care unit isolates of Staphylococcus epidermidis. J Hosp Infect 52(3): 212-
218. 
Fluckiger, U., M. Ulrich, A. Steinhuber, et al. (2005). Biofilm formation, icaADBC transcription, and 
polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect 
Immun 73(3): 1811-1819. 
Fluit, A. C., M. R. Visser and F. J. Schmitz (2001). Molecular detection of antimicrobial resistance. Clin 
Microbiol Rev 14(4): 836-871, table of contents. 
França, A., A. I. Freitas, A. F. Henriques and N. Cerca (2012). Optimizing a qPCR gene expression 
quantification assay for S. epidermidis biofilms: a comparison between commercial kits and a customized 
protocol. PLoS One 7(5): e37480. 
Francois, P., P. H. Tu Quoc, C. Bisognano, et al. (2003). Lack of biofilm contribution to bacterial 
colonisation in an experimental model of foreign body infection by Staphylococcus aureus and 
Staphylococcus epidermidis. FEMS Immunol Med Microbiol 35(2): 135-140. 
Frebourg, N. B., S. Lefebvre, S. Baert and J. F. Lemeland (2000). PCR-Based assay for discrimination 
between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol 38(2): 877-880. 
Fredheim, E. G., C. Klingenberg, H. Rohde, et al. (2009). Biofilm formation by Staphylococcus 
haemolyticus. J Clin Microbiol 47(4): 1172-1180. 
Galdbart, J. O., J. Allignet, H. S. Tung, C. Ryden and N. El Solh (2000). Screening for Staphylococcus 
epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint 
prostheses. J Infect Dis 182(1): 351-355. 
Gao, Z., C. H. Tseng, Z. Pei and M. J. Blaser (2007). Molecular analysis of human forearm superficial skin 
bacterial biota. Proc Natl Acad Sci U S A 104(8): 2927-2932. 
Garrett, D. O., E. Jochimsen, K. Murfitt, et al. (1999). The emergence of decreased susceptibility to 
vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol 20(3): 167-170. 
George, C. G. and W. E. Kloos (1994). Comparison of the SmaI-digested chromosomes of Staphylococcus 
epidermidis and the closely related species Staphylococcus capitis and Staphylococcus caprae. Int J Syst 
Bacteriol 44(3): 404-409. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
74 
 
Gerke, C., A. Kraft, R. Sussmuth, O. Schweitzer and F. Gotz (1998). Characterization of the N-
acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis 
polysaccharide intercellular adhesin. J Biol Chem 273(29): 18586-18593. 
Ghadiri, H., H. Vaez, S. Khosravi and E. Soleymani (2012). The antibiotic resistance profiles of bacterial 
strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res 
Pract 2012: 890797. 
Ghebremedhin, B., F. Layer, W. Konig and B. Konig (2008). Genetic classification and distinguishing of 
Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. 
J Clin Microbiol 46(3): 1019-1025. 
Gill, S. R., D. E. Fouts, G. L. Archer, et al. (2005). Insights on evolution of virulence and resistance from the 
complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-
producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187(7): 2426-2438. 
Goh, S. H., S. Potter, J. O. Wood, et al. (1996). HSP60 gene sequences as universal targets for microbial 
species identification: studies with coagulase-negative staphylococci. J Clin Microbiol 34(4): 818-823. 
Goldman, M., G. Delage, P. Beauregard, et al. (2001). A fatal case of transfusion-transmitted Staphylococcus 
epidermidis sepsis. Transfusion 41(8): 1075-1076. 
Götz, F., T. Bannerman and K. H. Schleifer (2006). The Genera Staphylococcus and Macrococcus. The 
Prokaryotes: Vol. 2: Ecophysiology and Biochemistry 
S. Falkow, E. Rosenberg, K. H. Schleifer, E. Stackebrandt and M. Dworkin, Springer. 
Grant, C. E., D. L. Sewell, M. Pfaller, R. V. Bumgardner and J. A. Williams (1994). Evaluation of two 
commercial systems for identification of coagulase-negative staphylococci to species level. Diagn Microbiol 
Infect Dis 18(1): 1-5. 
Grice, E. A., H. H. Kong, S. Conlan, et al. (2009). Topographical and temporal diversity of the human skin 
microbiome. Science 324(5931): 1190-1192. 
Gu, J., H. Li, M. Li, et al. (2005). Bacterial insertion sequence IS256 as a potential molecular marker to 
discriminate invasive strains from commensal strains of Staphylococcus epidermidis. J Hosp Infect 61(4): 
342-348. 
Hall-Stoodley, L., F. Z. Hu, A. Gieseke, et al. (2006). Direct detection of bacterial biofilms on the middle-ear 
mucosa of children with chronic otitis media. JAMA 296(2): 202-211. 
Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for 
Windows 95/98/NT. Nucleic Acids Symp Ser 41: 95-98. 
Heikens, E., A. Fleer, A. Paauw, A. Florijn and A. C. Fluit (2005). Comparison of genotypic and phenotypic 
methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J Clin 
Microbiol 43(5): 2286-2290. 
Heilig, S., P. Lee and L. Breslow (2002). Curtailing antibiotic use in agriculture: it is time for action: this use 
contributes to bacterial resistance in humans. West J Med 176(1): 9-11. 
Heilmann, C., M. Hussain, G. Peters and F. Gotz (1997). Evidence for autolysin-mediated primary 
attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol 24(5): 1013-1024. 
Heilmann, C., O. Schweitzer, C. Gerke, et al. (1996). Molecular basis of intercellular adhesion in the biofilm-
forming Staphylococcus epidermidis. Mol Microbiol 20(5): 1083-1091. 
Heilmann, C., G. Thumm, G. S. Chhatwal, et al. (2003). Identification and characterization of a novel 
autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology 149(Pt 10): 2769-
2778. 
Hellmark, B., B. Soderquist and M. Unemo (2009). Simultaneous species identification and detection of 
rifampicin resistance in staphylococci by sequencing of the rpoB gene. Eur J Clin Microbiol Infect Dis 28(2): 
183-190. 
Hellmark, B., B. Soderquist, M. Unemo and A. Nilsdotter-Augustinsson (2013). Comparison of 
Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to 
antibiotic susceptibility, agr type, biofilm production, and epidemiology. Int J Med Microbiol 303(1): 32-39. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
75 
 
Horan, T. C., M. Andrus and M. A. Dudeck (2008). CDC/NHSN surveillance definition of health care-
associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 
36(5): 309-332. 
Hurford, A., A. M. Morris, D. N. Fisman and J. Wu (2012). Linking antimicrobial prescribing to 
antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program. Epidemics 4(4): 
203-210. 
Hussain, M., M. Herrmann, C. von Eiff, F. Perdreau-Remington and G. Peters (1997). A 140-kilodalton 
extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. 
Infect Immun 65(2): 519-524. 
Hwang, S. M., M. S. Kim, K. U. Park, J. Song and E. C. Kim (2011). Tuf gene sequence analysis has greater 
discriminatory power than 16S rRNA sequence analysis in identification of clinical isolates of coagulase-
negative staphylococci. J Clin Microbiol 49(12): 4142-4149. 
Incani, R. N., M. Hernandez, J. Cortez, M. E. Gonzalez and Y. D. Salazar (2010). Staphylococcus warneri 
meningitis in a patient with Strongyloides stercoralis hyperinfection and lymphoma: first report of a case. 
Rev Inst Med Trop Sao Paulo 52(3): 169-170. 
Jain, A. and A. Agarwal (2009). Biofilm production, a marker of pathogenic potential of colonizing and 
commensal staphylococci. J Microbiol Methods 76(1): 88-92. 
John, J. F. and A. M. Harvin (2007). History and evolution of antibiotic resistance in coagulase-negative 
staphylococci: Susceptibility profiles of new anti-staphylococcal agents. Ther Clin Risk Manag 3(6): 1143-
1152. 
Jones, K. E., N. G. Patel, M. A. Levy, et al. (2008). Global trends in emerging infectious diseases. Nature 
451(7181): 990-993. 
Juarez-Verdayes, M. A., M. A. Reyes-Lopez, M. E. Cancino-Diaz, et al. (2006). Isolation, vancomycin 
resistance and biofilm production of Staphylococcus epidermidis from patients with conjunctivitis, corneal 
ulcers, and endophthalmitis. Rev Latinoam Microbiol 48(3-4): 238-246. 
Karacal, H., S. M. Kymes and R. S. Apte (2007). Retrospective analysis of etiopathogenesis of all cases of 
endophthalmitis at a large tertiary referral center. Int Ophthalmol 27(4): 251-259. 
Kini, G. D., K. Patel, A. R. Parris and J. S. Tang (2010). An Unusual Presentation of Endocarditis Caused by 
Staphylococcus warneri. Open Microbiol J 4: 103-105. 
Kinney, C. A., E. T. Furlong, S. D. Zaugg, et al. (2006). Survey of organic wastewater contaminants in 
biosolids destined for land application. Environ Sci Technol 40(23): 7207-7215. 
Klevens, R. M., J. R. Edwards, C. L. Richards, Jr., et al. (2007). Estimating health care-associated infections 
and deaths in U.S. hospitals, 2002. Public Health Rep 122(2): 160-166. 
Klingenberg, C., E. Aarag, A. Ronnestad, et al. (2005). Coagulase-negative staphylococcal sepsis in 
neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response. 
Pediatr Infect Dis J 24(9): 817-822. 
Kloos, W. E., C. G. George, J. S. Olgiate, et al. (1998). Staphylococcus hominis subsp. novobiosepticus 
subsp. nov., a novel trehalose- and N-acetyl-D-glucosamine-negative, novobiocin- and multiple-antibiotic-
resistant subspecies isolated from human blood cultures. Int J Syst Bacteriol 48 Pt 3: 799-812. 
Kloos, W. E. and M. S. Musselwhite (1975). Distribution and persistence of Staphylococcus and 
Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 30(3): 381-385. 
Kloos, W. E. and K. H. Schleifer (1975). Isolation and Characterization of Staphylococci from Human Skin 
II. Descriptions of Four New Species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus 
hominis, and Staphylococcus simulans. Int J Syst Bacteriol 25(1): 62-79. 
Knobloch, J. K., S. Jager, M. A. Horstkotte, H. Rohde and D. Mack (2004). RsbU-dependent regulation of 
Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by 
repression of the negative regulator gene icaR. Infect Immun 72(7): 3838-3848. 
Kocianova, S., C. Vuong, Y. Yao, et al. (2005). Key role of poly-gamma-DL-glutamic acid in immune 
evasion and virulence of Staphylococcus epidermidis. J Clin Invest 115(3): 688-694. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
76 
 
Kollef, M. H., L. M. Napolitano, J. S. Solomkin, et al. (2008). Health care-associated infection (HAI): a 
critical appraisal of the emerging threat-proceedings of the HAI Summit. Clin Infect Dis 47 Suppl 2: S55-99; 
quiz S100-101. 
Kong, H. H. and J. A. Segre (2012). Skin microbiome: looking back to move forward. J Invest Dermatol 
132(3 Pt 2): 933-939. 
Koskela, A., A. Nilsdotter-Augustinsson, L. Persson and B. Soderquist (2009). Prevalence of the ica operon 
and insertion sequence IS256 among Staphylococcus epidermidis prosthetic joint infection isolates. Eur J 
Clin Microbiol Infect Dis 28(6): 655-660. 
Kotilainen, P., J. Nikoskelainen and P. Huovinen (1991). Antibiotic susceptibility of coagulase-negative 
staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus 
epidermidis strains. Scand J Infect Dis 23(3): 325-332. 
Kozitskaya, S., S. H. Cho, K. Dietrich, et al. (2004). The bacterial insertion sequence element IS256 occurs 
preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and 
resistance to aminoglycosides. Infect Immun 72(2): 1210-1215. 
Kummerer, K. (2003). Significance of antibiotics in the environment. J Antimicrob Chemother 52(1): 5-7. 
Kummerer, K. (2004). Resistance in the environment. J Antimicrob Chemother 54(2): 311-320. 
Lai, Y., A. E. Villaruz, M. Li, et al. (2007). The human anionic antimicrobial peptide dermcidin induces 
proteolytic defence mechanisms in staphylococci. Mol Microbiol 63(2): 497-506. 
Lambe, D. W., Jr., K. P. Ferguson, J. L. Keplinger, C. G. Gemmell and J. H. Kalbfleisch (1990). 
Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative 
staphylococci in a mouse model and possible virulence factors. Can J Microbiol 36(7): 455-463. 
Larkin, M. A., G. Blackshields, N. P. Brown, et al. (2007). Clustal W and Clustal X version 2.0. 
Bioinformatics 23(21): 2947-2948. 
Layer, F., B. Ghebremedhin, K. A. Moder, W. Konig and B. Konig (2006). Comparative study using various 
methods for identification of Staphylococcus species in clinical specimens. J Clin Microbiol 44(8): 2824-
2830. 
Leid, J. G., M. E. Shirtliff, J. W. Costerton and P. Stoodley (2002). Human leukocytes adhere to, penetrate, 
and respond to Staphylococcus aureus biofilms. Infect Immun 70(11): 6339-6345. 
Lentino, J. R., M. Narita and V. L. Yu (2008). New antimicrobial agents as therapy for resistant gram-
positive cocci. Eur J Clin Microbiol Infect Dis 27(1): 3-15. 
Levy, S. B. (2000). Antibiotic and antiseptic resistance: impact on public health. Pediatr Infect Dis J 19(10 
Suppl): S120-122. 
Levy, S. B. (2002). The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J 
Antimicrob Chemother 49(1): 25-30. 
Levy, S. B. and B. Marshall (2004). Antibacterial resistance worldwide: causes, challenges and responses. 
Nat Med 10(12 Suppl): S122-129. 
Lewis, K. (2007). Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5(1): 48-56. 
Li, H., L. Xu, J. Wang, et al. (2005). Conversion of Staphylococcus epidermidis strains from commensal to 
invasive by expression of the ica locus encoding production of biofilm exopolysaccharide. Infect Immun 
73(5): 3188-3191. 
Linares, J. F., I. Gustafsson, F. Baquero and J. L. Martinez (2006). Antibiotics as intermicrobial signaling 
agents instead of weapons. Proc Natl Acad Sci U S A 103(51): 19484-19489. 
Lindsay, J. A., M. A. Aravena-Roman and T. V. Riley (1993). Identification of Staphylococcus epidermidis 
and Staphylococcus hominis from blood cultures by testing susceptibility to desferrioxamine. Eur J Clin 
Microbiol Infect Dis 12(2): 127-131. 
Linnes, J. C., H. Ma and J. D. Bryers (2013). Giant Extracellular Matrix Binding Protein Expression in 
Staphylococcus epidermidis is Regulated by Biofilm Formation and Osmotic Pressure. Curr Microbiol 66(6): 
627-633. 
Livermore, D. M. (2000). Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16 Suppl 1: S3-10. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
77 
 
Loiez, C., F. Wallet, P. Pischedda, et al. (2007). First case of osteomyelitis caused by "Staphylococcus 
pettenkoferi". J Clin Microbiol 45(3): 1069-1071. 
Longauerova, A. (2006). Coagulase negative staphylococci and their participation in pathogenesis of human 
infections. Bratisl Lek Listy 107(11-12): 448-452. 
Longshaw, C. M., A. M. Farrell, J. D. Wright and K. T. Holland (2000). Identification of a second lipase 
gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal 
lipases. Microbiology 146 ( Pt 6): 1419-1427. 
Macintosh, R. L., J. L. Brittan, R. Bhattacharya, et al. (2009). The terminal A domain of the fibrillar 
accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human 
corneocytes. J Bacteriol 191(22): 7007-7016. 
Mack, D., W. Fischer, A. Krokotsch, et al. (1996). The intercellular adhesin involved in biofilm 
accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and 
structural analysis. J Bacteriol 178(1): 175-183. 
Mack, D., M. Nedelmann, A. Krokotsch, et al. (1994). Characterization of transposon mutants of biofilm-
producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic 
identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun 62(8): 3244-
3253. 
Maira-Litran, T., A. Kropec, C. Abeygunawardana, et al. (2002). Immunochemical properties of the 
staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun 70(8): 4433-4440. 
Marshall, B. M., D. J. Ochieng and S. B. Levy (2009). Commensals: Underappreciated Reservoir of 
Antibiotic Resistance. Microbe 4(5): 231-238. 
Marsou, R., M. Bes, Y. Brun, et al. (2001). Molecular techniques open up new vistas for typing of coagulase-
negative staphylococci. Pathol Biol (Paris) 49(3): 205-215. 
Martin-Davila, P., E. Navas, J. Fortun, et al. (2005). Analysis of mortality and risk factors associated with 
native valve endocarditis in drug users: the importance of vegetation size. Am Heart J 150(5): 1099-1106. 
Martinez-Lage, J. F., L. Martinez-Lage Azorin and M. J. Almagro (2010). Staphylococcus warneri 
ventriculoperitoneal shunt infection: failure of diagnosis by ventricular CSF sampling. Childs Nerv Syst 
26(12): 1795-1798. 
Martinez, J. L. (2008). Antibiotics and antibiotic resistance genes in natural environments. Science 
321(5887): 365-367. 
Martinez, J. L. (2009). Environmental pollution by antibiotics and by antibiotic resistance determinants. 
Environ Pollut 157(11): 2893-2902. 
Mazzoli, S. (2010). Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS 
Immunol Med Microbiol 59(3): 337-344. 
McEwen, S. A. and P. J. Fedorka-Cray (2002). Antimicrobial use and resistance in animals. Clin Infect Dis 
34 Suppl 3: S93-S106. 
McManus, M. C. (1997). Mechanisms of bacterial resistance to antimicrobial agents. Am J Health Syst 
Pharm 54(12): 1420-1433; quiz 1444-1426. 
McMurry, L. M., M. Oethinger and S. B. Levy (1998). Triclosan targets lipid synthesis. Nature 394(6693): 
531-532. 
Mellmann, A., K. Becker, C. von Eiff, et al. (2006). Sequencing and staphylococci identification. Emerg 
Infect Dis 12(2): 333-336. 
Mendoza-Olazaran, S., R. Morfin-Otero, E. Rodriguez-Noriega, et al. (2013). Microbiological and Molecular 
Characterization of Staphylococcus hominis Isolates from Blood. PLoS One 8(4): e61161. 
Mihaila, L., G. Defrance, E. Levesque, et al. (2012). A dual outbreak of bloodstream infections with 
linezolid-resistant Staphylococcus epidermidis and Staphylococcus pettenkoferi in a liver Intensive Care Unit. 
Int J Antimicrob Agents 40(5): 472-474. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
78 
 
Miragaia, M., J. C. Thomas, I. Couto, M. C. Enright and H. de Lencastre (2007). Inferring a population 
structure for Staphylococcus epidermidis from multilocus sequence typing data. J Bacteriol 189(6): 2540-
2552. 
Monsen, T., C. Karlsson and J. Wistrom (2005). Spread of clones of multidrug-resistant, coagulase-negative 
staphylococci within a university hospital. Infect Control Hosp Epidemiol 26(1): 76-80. 
Monsen, T., C. Olofsson, M. Ronnmark and J. Wistrom (2000). Clonal spread of staphylococci among 
patients with peritonitis associated with continuous ambulatory peritoneal dialysis. Kidney Int 57(2): 613-
618. 
Montanaro, L., D. Campoccia, V. Pirini, et al. (2007). Antibiotic multiresistance strictly associated with 
IS256 and ica genes in Staphylococcus epidermidis strains from implant orthopedic infections. J Biomed 
Mater Res A 83(3): 813-818. 
Munoz, P., E. Bouza, R. San Juan, et al. (2004). Clinical-epidemiological characteristics and outcome of 
patients with catheter-related bloodstream infections in Europe (ESGNI-006 Study). Clin Microbiol Infect 
10(9): 843-845. 
Nayak, N., G. Satpathy, H. L. Nag, et al. (2011). Slime production is essential for the adherence of 
Staphylococcus epidermidis in implant-related infections. J Hosp Infect 77(2): 153-156. 
Ng, P. C., V. C. Chow, C. H. Lee, et al. (2006). Persistent Staphylococcus capitis septicemia in a preterm 
infant. Pediatr Infect Dis J 25(7): 652-654. 
Nilsson, M., L. Frykberg, J. I. Flock, et al. (1998). A fibrinogen-binding protein of Staphylococcus 
epidermidis. Infect Immun 66(6): 2666-2673. 
Nováková, D., I. Sedlácek, R. Pantucek, et al. (2006). Staphylococcus equorum and Staphylococcus succinus 
isolated from human clinical specimens. J Med Microbiol 55(Pt 5): 523-528. 
Nunes, A. P., L. M. Teixeira, N. L. Iorio, et al. (2006). Heterogeneous resistance to vancomycin in 
Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: 
characterisation of glycopeptide susceptibility profiles and cell wall thickening. Int J Antimicrob Agents 
27(4): 307-315. 
O'Gara, J. P. and H. Humphreys (2001). Staphylococcus epidermidis biofilms: importance and implications. J 
Med Microbiol 50(7): 582-587. 
O'Toole, G. A. (2003). To build a biofilm. J Bacteriol 185(9): 2687-2689. 
Otto, M. (2004). Virulence factors of the coagulase-negative staphylococci. Front Biosci 9: 841-863. 
Otto, M. (2009). Staphylococcus epidermidis - the 'accidental' pathogen. Nat Rev Microbiol 7(8): 555-567. 
Otto, M. (2010). Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol 
5(2): 183-195. 
Otto, M. (2012). Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol 34(2): 201-
214. 
Palazzo, I. C., M. L. Araujo and A. L. Darini (2005). First report of vancomycin-resistant staphylococci 
isolated from healthy carriers in Brazil. J Clin Microbiol 43(1): 179-185. 
Pallecchi, L., C. Lucchetti, A. Bartoloni, et al. (2007). Population structure and resistance genes in antibiotic-
resistant bacteria from a remote community with minimal antibiotic exposure. Antimicrob Agents Chemother 
51(4): 1179-1184. 
Patel, J. D., E. Colton, M. Ebert and J. M. Anderson (2012). Gene expression during S. epidermidis biofilm 
formation on biomaterials. J Biomed Mater Res A 100(11): 2863-2869. 
Pei, L., M. Palma, M. Nilsson, B. Guss and J. I. Flock (1999). Functional studies of a fibrinogen binding 
protein from Staphylococcus epidermidis. Infect Immun 67(9): 4525-4530. 
Piette, A. and G. Verschraegen (2009). Role of coagulase-negative staphylococci in human disease. Vet 
Microbiol 134(1-2): 45-54. 
Pina, E., J. A. Paiva, P. Nogueira and M. G. Silva (2013). Prevalência de infeção adquirida no hospital e do 
uso de antimicrobianos nos hospitais portugueses - Inquérito 2012, Direção-Geral da Saúde. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
79 
 
Pina, P., C. Marliere, F. Vandenesch, et al. (2000). An outbreak of Staphylococcus aureus strains with 
reduced susceptibility to glycopeptides in a French general hospital. Clin Infect Dis 31(5): 1306-1308. 
Pittet, D., B. Allegranzi, J. Storr, et al. (2008). Infection control as a major World Health Organization 
priority for developing countries. J Hosp Infect 68(4): 285-292. 
Potter, A., H. Ceotto, M. Giambiagi-Demarval, et al. (2009). The gene bap, involved in biofilm production, 
is present in Staphylococcus spp. strains from nosocomial infections. J Microbiol 47(3): 319-326. 
Poutsiaka, D. D., L. L. Price, A. Ucuzian, et al. (2007). Blood stream infection after hematopoietic stem cell 
transplantation is associated with increased mortality. Bone Marrow Transplant 40(1): 63-70. 
Poyart, C., G. Quesne, C. Boumaila and P. Trieu-Cuot (2001). Rapid and accurate species-level identification 
of coagulase-negative staphylococci by using the sodA gene as a target. J Clin Microbiol 39(12): 4296-4301. 
Qin, Z., X. Yang, L. Yang, et al. (2007). Formation and properties of in vitro biofilms of ica-negative 
Staphylococcus epidermidis clinical isolates. J Med Microbiol 56(Pt 1): 83-93. 
Rambaut, A. (2012). FigTree v1.4.0: Tree figure drawing tool. Available at 
http://tree.bio.ed.ac.uk/software/figtree/ [Accessed 28 March 2013] 
Raz, R., R. Colodner and C. M. Kunin (2005). Who are you - Staphylococcus saprophyticus? Clin Infect Dis 
40(6): 896-898. 
Ren, D., L. A. Bedzyk, S. M. Thomas, R. W. Ye and T. K. Wood (2004). Gene expression in Escherichia 
coli biofilms. Appl Microbiol Biotechnol 64(4): 515-524. 
Renneberg, J., K. Rieneck and E. Gutschik (1995). Evaluation of Staph ID 32 system and Staph-Zym system 
for identification of coagulase-negative staphylococci. J Clin Microbiol 33(5): 1150-1153. 
Resch, A., R. Rosenstein, C. Nerz and F. Gotz (2005). Differential gene expression profiling of 
Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol 71(5): 
2663-2676. 
Richards, M. J., J. R. Edwards, D. H. Culver and R. P. Gaynes (2000). Nosocomial infections in combined 
medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21(8): 510-515. 
Rogers, K. L., M. E. Rupp and P. D. Fey (2008). The presence of icaADBC is detrimental to the colonization 
of human skin by Staphylococcus epidermidis. Appl Environ Microbiol 74(19): 6155-6157. 
Rohde, H., E. C. Burandt, N. Siemssen, et al. (2007). Polysaccharide intercellular adhesin or protein factors 
in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic 
hip and knee joint infections. Biomaterials 28(9): 1711-1720. 
Rohde, H., C. Burdelski, K. Bartscht, et al. (2005). Induction of Staphylococcus epidermidis biofilm 
formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host 
proteases. Mol Microbiol 55(6): 1883-1895. 
Rohde, H., S. Frankenberger, U. Zahringer and D. Mack (2010). Structure, function and contribution of 
polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis 
of biomaterial-associated infections. Eur J Cell Biol 89(1): 103-111. 
Rohde, H., M. Kalitzky, N. Kroger, et al. (2004). Detection of virulence-associated genes not useful for 
discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow 
transplant unit. J Clin Microbiol 42(12): 5614-5619. 
Rohde, H., D. Mack, M. Christner, et al. (2006). Pathogenesis of staphylococcal device-related infections: 
from basic science to new diagnostic, therapeutic and prophylactic approaches. Reviews in Medical 
Microbiology 17(2): 45-54 10.1097/1001.revmedmi.0000244134.0000243170.0000244183. 
Rupp, M. E., P. D. Fey, C. Heilmann and F. Gotz (2001). Characterization of the importance of 
Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of 
intravascular catheter-associated infection in a rat model. J Infect Dis 183(7): 1038-1042. 
Rupp, M. E., J. S. Ulphani, P. D. Fey, K. Bartscht and D. Mack (1999a). Characterization of the importance 
of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of 
biomaterial-based infection in a mouse foreign body infection model. Infect Immun 67(5): 2627-2632. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
80 
 
Rupp, M. E., J. S. Ulphani, P. D. Fey and D. Mack (1999b). Characterization of Staphylococcus epidermidis 
polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated 
infection in a rat model. Infect Immun 67(5): 2656-2659. 
Schleifer, K. H., R. Kilpper-Bälz and L. A. Devriese (1984). Staphylococcus arlettae sp. nov., S. equorum sp. 
nov. and S. kloosii sp. nov.: Three New Coagulase-Negative, Novobiocin-Resistant Species from Animals. 
Syst Appl Microbiol 5(4): 501-509. 
Schleifer, K. H. and W. E. Kloos (1975). Isolation and Characterization of Staphylococci from Human Skin 
I. Amended Descriptions of Staphylococcus epidermidis and Staphylococcus saprophyticus and Descriptions 
of Three New Species: Staphylococcus cohnii, Staphylococcus haemolyticus, and Staphylococcus xylosus. Int 
J Syst Bacteriol 25(1): 50-61. 
Schoenfelder, S. M., C. Lange, M. Eckart, et al. (2010). Success through diversity - how Staphylococcus 
epidermidis establishes as a nosocomial pathogen. Int J Med Microbiol 300(6): 380-386. 
Schommer, N. N., M. Christner, M. Hentschke, et al. (2011). Staphylococcus epidermidis uses distinct 
mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like 
cells 774A.1. Infect Immun 79(6): 2267-2276. 
Schwalbe, R. S., J. T. Stapleton and P. H. Gilligan (1987). Emergence of vancomycin resistance in 
coagulase-negative staphylococci. N Engl J Med 316(15): 927-931. 
Shah, M. M., H. Iihara, M. Noda, et al. (2007). dnaJ gene sequence-based assay for species identification and 
phylogenetic grouping in the genus Staphylococcus. Int J Syst Evol Microbiol 57(Pt 1): 25-30. 
Sharma, V., N. Jindal and P. Devi (2010). Prevalence of methicillin resistant coagulase negative 
staphylococci in a tertiary care hospital. Iran J Microbiol 2(4): 185-188. 
Shin, J. H., S. H. Kim, H. S. Jeong, et al. (2011). Identification of coagulase-negative staphylococci isolated 
from continuous ambulatory peritoneal dialysis fluid using 16S ribosomal RNA, tuf, and sodA gene 
sequencing. Perit Dial Int 31(3): 340-346. 
Slaughter, D. M., T. G. Patton, G. Sievert, R. J. Sobieski and S. S. Crupper (2001). Antibiotic resistance in 
coagulase-negative staphylococci isolated from Cope's gray treefrogs (Hyla chrysoscelis). FEMS Microbiol 
Lett 205(2): 265-270. 
Sommer, M. O., G. Dantas and G. M. Church (2009). Functional characterization of the antibiotic resistance 
reservoir in the human microflora. Science 325(5944): 1128-1131. 
Song, S. H., J. S. Park, H. R. Kwon, et al. (2009). Human bloodstream infection caused by Staphylococcus 
pettenkoferi. J Med Microbiol 58(Pt 2): 270-272. 
Stanley, N. R., R. A. Britton, A. D. Grossman and B. A. Lazazzera (2003). Identification of catabolite 
repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays. 
J Bacteriol 185(6): 1951-1957. 
Steinke, D. and P. Davey (2001). Association between antibiotic resistance and community prescribing: a 
critical review of bias and confounding in published studies. Clin Infect Dis 33 Suppl 3: S193-205. 
Stepanovic, S., D. Vukovic, V. Hola, et al. (2007). Quantification of biofilm in microtiter plates: overview of 
testing conditions and practical recommendations for assessment of biofilm production by staphylococci. 
APMIS 115(8): 891-899. 
Stevens, N. T., M. Tharmabala, T. Dillane, et al. (2008). Biofilm and the role of the ica operon and aap in 
Staphylococcus epidermidis isolates causing neurosurgical meningitis. Clin Microbiol Infect 14(7): 719-722. 
Stewart, P. S. (1998). A review of experimental measurements of effective diffusive permeabilities and 
effective diffusion coefficients in biofilms. Biotechnol Bioeng 59(3): 261-272. 
Stollberger, C., A. Wechsler-Fordos, F. Geppert, et al. (2006). Staphylococcus warneri endocarditis after 
implantation of a lumbar disc prosthesis in an immunocompetent patient. J Infect 52(1): e15-18. 
Stoodley, P., K. Sauer, D. G. Davies and J. W. Costerton (2002). Biofilms as complex differentiated 
communities. Annu Rev Microbiol 56: 187-209. 
Sunbul, M., M. K. Demirag, O. Yilmaz, et al. (2006). Pacemaker lead endocarditis caused by Staphylococcus 
hominis. Pacing Clin Electrophysiol 29(5): 543-545. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
81 
 
Swidsinski, A., W. Mendling, V. Loening-Baucke, et al. (2005). Adherent biofilms in bacterial vaginosis. 
Obstet Gynecol 106(5 Pt 1): 1013-1023. 
Takano, T., Y. Ohtsu, T. Terasaki, Y. Wada and J. Amano (2011). Prosthetic valve endocarditis caused by 
Staphylococcus capitis: report of 4 cases. J Cardiothorac Surg 6: 131. 
Tan, T. Y., S. Y. Ng and W. X. Ng (2006). Clinical significance of coagulase-negative staphylococci 
recovered from nonsterile sites. J Clin Microbiol 44(9): 3413-3414. 
Tenover, F. C. (2006). Mechanisms of antimicrobial resistance in bacteria. Am J Med 119(6 Suppl 1): S3-10; 
discussion S62-70. 
Thaller, M. C., L. Migliore, C. Marquez, et al. (2010). Tracking acquired antibiotic resistance in commensal 
bacteria of Galapagos land iguanas: no man, no resistance. PLoS One 5(2): e8989. 
Topp, E., S. C. Monteiro, A. Beck, et al. (2008). Runoff of pharmaceuticals and personal care products 
following application of biosolids to an agricultural field. Sci Total Environ 396(1): 52-59. 
Tormo, M. A., E. Knecht, F. Gotz, I. Lasa and J. R. Penades (2005). Bap-dependent biofilm formation by 
pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology 151(Pt 7): 2465-
2475. 
Tormo, M. A., M. Marti, J. Valle, et al. (2005). SarA is an essential positive regulator of Staphylococcus 
epidermidis biofilm development. J Bacteriol 187(7): 2348-2356. 
Trulzsch, K., B. Grabein, P. Schumann, et al. (2007). Staphylococcus pettenkoferi sp. nov., a novel 
coagulase-negative staphylococcal species isolated from human clinical specimens. Int J Syst Evol Microbiol 
57(Pt 7): 1543-1548. 
Vadyvaloo, V. and M. Otto (2005). Molecular genetics of Staphylococcus epidermidis biofilms on indwelling 
medical devices. Int J Artif Organs 28(11): 1069-1078. 
Vandecasteele, S. J., W. E. Peetermans, R. M. R, B. J. Rijnders and J. Van Eldere (2003). Reliability of the 
ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus 
epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 9(2): 114-119. 
Venkatesh, M. P., F. Placencia and L. E. Weisman (2006). Coagulase-negative staphylococcal infections in 
the neonate and child: an update. Semin Pediatr Infect Dis 17(3): 120-127. 
Viale, P. and S. Stefani (2006). Vascular catheter-associated infections: a microbiological and therapeutic 
update. J Chemother 18(3): 235-249. 
Vogel, L., J. H. Sloos, J. Spaargaren, I. Suiker and L. Dijkshoorn (2000). Biofilm production by 
Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis 
36(2): 139-141. 
von Eiff, C., B. Jansen, W. Kohnen and K. Becker (2005). Infections associated with medical devices: 
pathogenesis, management and prophylaxis. Drugs 65(2): 179-214. 
von Eiff, C., G. Peters and C. Heilmann (2002). Pathogenesis of infections due to coagulase-negative 
staphylococci. Lancet Infect Dis 2(11): 677-685. 
Vuong, C., M. Durr, A. B. Carmody, et al. (2004). Regulated expression of pathogen-associated molecular 
pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and 
production of phenol-soluble modulins. Cell Microbiol 6(8): 753-759. 
Vuong, C., C. Gerke, G. A. Somerville, E. R. Fischer and M. Otto (2003). Quorum-sensing control of biofilm 
factors in Staphylococcus epidermidis. J Infect Dis 188(5): 706-718. 
Vuong, C., S. Kocianova, J. M. Voyich, et al. (2004). A crucial role for exopolysaccharide modification in 
bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279(52): 54881-54886. 
Vuong, C., S. Kocianova, Y. Yao, A. B. Carmody and M. Otto (2004). Increased colonization of indwelling 
medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis 190(8): 
1498-1505. 
Wang, A., E. Athan, P. A. Pappas, et al. (2007). Contemporary clinical profile and outcome of prosthetic 
valve endocarditis. JAMA 297(12): 1354-1361. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
82 
 
Wang, R., K. R. Braughton, D. Kretschmer, et al. (2007). Identification of novel cytolytic peptides as key 
virulence determinants for community-associated MRSA. Nat Med 13(12): 1510-1514. 
Weinstein, M. P., S. Mirrett, L. Van Pelt, et al. (1998). Clinical importance of identifying coagulase-negative 
staphylococci isolated from blood cultures: evaluation of MicroScan Rapid and Dried Overnight Gram-
Positive panels versus a conventional reference method. J Clin Microbiol 36(7): 2089-2092. 
Wellington, E. M., A. B. Boxall, P. Cross, et al. (2013). The role of the natural environment in the emergence 
of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis 13(2): 155-165. 
Whiteley, M., M. G. Bangera, R. E. Bumgarner, et al. (2001). Gene expression in Pseudomonas aeruginosa 
biofilms. Nature 413(6858): 860-864. 
WHO (2011). Report on the Burden of Endemic Health Care-Associated Infection Worldwide: a systematic 
review of the literature. Geneva, WHO. 
Widerstrom, M., T. Monsen, C. Karlsson and J. Wistrom (2006). Molecular epidemiology of meticillin-
resistant coagulase-negative staphylococci in a Swedish county hospital: evidence of intra- and interhospital 
clonal spread. J Hosp Infect 64(2): 177-183. 
Widerstrom, M., J. Wistrom, E. Ek, H. Edebro and T. Monsen (2011). Near absence of methicillin-resistance 
and pronounced genetic diversity among Staphylococcus epidermidis isolated from healthy persons in 
northern Sweden. APMIS 119(8): 505-512. 
Widerstrom, M., J. Wistrom, S. Ferry, C. Karlsson and T. Monsen (2007). Molecular epidemiology of 
Staphylococcus saprophyticus isolated from women with uncomplicated community-acquired urinary tract 
infection. J Clin Microbiol 45(5): 1561-1564. 
Williams, R. J., B. Henderson, L. J. Sharp and S. P. Nair (2002). Identification of a fibronectin-binding 
protein from Staphylococcus epidermidis. Infect Immun 70(12): 6805-6810. 
Wisplinghoff, H., T. Bischoff, S. M. Tallent, et al. (2004). Nosocomial bloodstream infections in US 
hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3): 
309-317. 
Wisplinghoff, H., H. Seifert, R. P. Wenzel and M. B. Edmond (2003). Current trends in the epidemiology of 
nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in 
hospitals in the United States. Clin Infect Dis 36(9): 1103-1110. 
Wright, G. D. (2010). Antibiotic resistance in the environment: a link to the clinic? Curr Opin Microbiol 
13(5): 589-594. 
Xu, L., H. Li, C. Vuong, et al. (2006). Role of the luxS quorum-sensing system in biofilm formation and 
virulence of Staphylococcus epidermidis. Infect Immun 74(1): 488-496. 
Yao, Y., D. E. Sturdevant and M. Otto (2005). Genomewide analysis of gene expression in Staphylococcus 
epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-
soluble modulins in formation of biofilms. J Infect Dis 191(2): 289-298. 
Yugueros, J., A. Temprano, B. Berzal, et al. (2000). Glyceraldehyde-3-phosphate dehydrogenase-encoding 
gene as a useful taxonomic tool for Staphylococcus spp. J Clin Microbiol 38(12): 4351-4355. 
Zadoks, R. N. and J. L. Watts (2009). Species identification of coagulase-negative staphylococci: genotyping 
is superior to phenotyping. Vet Microbiol 134(1-2): 20-28. 
Zhang, Y. Q., S. X. Ren, H. L. Li, et al. (2003). Genome-based analysis of virulence genes in a non-biofilm-
forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol 49(6): 1577-1593. 
Ziebuhr, W., K. Dietrich, M. Trautmann and M. Wilhelm (2000). Chromosomal rearrangements affecting 
biofilm production and antibiotic resistance in a Staphylococcus epidermidis strain causing shunt-associated 
ventriculitis. Int J Med Microbiol 290(1): 115-120. 
Ziebuhr, W., C. Heilmann, F. Gotz, et al. (1997). Detection of the intercellular adhesion gene cluster (ica) 
and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 
65(3): 890-896. 
Ziebuhr, W., V. Krimmer, S. Rachid, et al. (1999). A novel mechanism of phase variation of virulence in 
Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by 
alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol 32(2): 345-356. 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
83 
 
Zijnge, V., M. B. van Leeuwen, J. E. Degener, et al. (2010). Oral biofilm architecture on natural teeth. PLoS 
One 5(2): e9321. 
 
 
 
 
 
 
 
  
 
  
 
Supplementary information 
Diversity and characterisation of CoNS isolated from healthy individuals 
 
86 
 
Appendix A - Questionnaire 
 INQUÉRITO 
 
Inquérito para estudo sobre a colonização da pele pela bactéria Staphylococcus epidermidis 
 
ID Amostra: Idade: Sexo: M     F  
Localidade: 
Profissão: 
1. Alguma vez esteve hospitalizado(a) nos últimos dois anos? 
a) Sim  b) Não 
1.1. Em caso afirmativo, especifique há quanto tempo ocorreu a hospitalização. 
_________________________________________________________________________ 
2. Durante o último ano esteve sob tratamento com antibióticos? 
a) Sim  b) Não 
2.1. Em caso afirmativo, especifique o antibiótico (ou a finalidade do tratamento). 
_________________________________________________________________________ 
3. Tem algum tipo de contacto com profissionais de saúde e/ ou pessoas que frequentem um ambiente hospitalar? 
a) Sim  b) Não 
4. Actualmente está a tomar algum tipo de medicação? 
a) Sim  b) Não 
4.1. Em caso afirmativo, especifique o(s) medicamento(s) (ou a sua finalidade). 
_________________________________________________________________________ 
 
5. Lava as mãos com frequência? 
a) Sim  b) Não 
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6. Toma banho todos os dias? 
a) Sim  b) Não 
7. Fuma com regularidade, ou está exposto(a) a ambientes com fumo? 
a) Sim  b) Não 
8. Apresenta alguma alergia, nomeadamente associada à pele? 
a) Sim  b) Não 
8.1. Em caso afirmativo, especifique o tipo de alergia. 
_________________________________________________________________________ 
9. Efectuou alguma tatuagem/ tratamento com acupunctura no último ano? 
a) Sim  b) Não 
10. Frequenta com regularidade locais públicos como piscinas, ginásios, saunas ou similar? 
a) Sim  b) Não 
 
 
Agradecemos a sua atenção! 
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Appendix B - Informed consent 
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Appendix C 
Gram staining 
Bacterial cells were initially smeared over a microscope slide and heat-fixed. Then, the 
smear was covered with crystal violet stain for 60 s. The stain was poured off and the 
excess stain was gently rinsed with running water. Afterwards, the smear was covered with 
Lugol’s solution for 60 s and subsequently rinsed with running water. In the following 
step, a few drops of 70% ethanol were added and allowed to trickle down the slide. The 
slide was gently rinsed with running water only when the solvent was no longer coloured. 
Lastly, the smear was covered with safranin solution for 30 s and gently rinsed with 
running water. The slide was dried with absorbent paper to remove the excess water. The 
smears were then examined under a light microscope in order to visualise the morphology 
(e.g., cocci, bacilli) and the reaction of the bacterial cells to Gram staining (purple, Gram-
positive; pink, Gram-negative). Staphylococcus epidermidis ATCC 35984 (Gram-positive 
cocci) and Escherichia coli ATCC 25922 (Gram-negative bacilli) were used as controls.  
Oxidase testing  
Oxidase strips (Oxoid, UK) containing NNN'N'-tetramethyl-p-phenylene-diamine  
dihydrochloride (TMPD) were used for oxidase testing. On each strip a small amount of 
the bacteria to be tested was added and observed after 20 s. The strip turned dark blue 
when in contact with oxidase-positive bacteria (due to the presence cytochrome c oxidase) 
and remained colourless in the case of oxidase-negative bacteria. Pseudomonas aeruginosa 
ATCC 10145 and Staphylococcus epidermidis ATCC 35984 were used as positive and 
negative controls, respectively. 
Catalase testing  
A small amount of the bacteria to be tested was placed onto a microscope slide. Then, a 
few drops of hydrogen peroxide were added over the bacteria. Formation of bubbles was 
indicative of a positive reaction, whereas no bubble formation indicated a negative 
reaction. Staphylococcus epidermidis ATCC 35984 and Gardnerella vaginalis AMD were 
used as positive and negative controls, respectively. 
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Appendix D - CFU enumeration 
The concentration of bacteria in the growth control wells (medium without antibiotic) of 
each MIC panel was determined through CFU enumeration. Immediately following 
inoculation of the MIC panel, 10 μl of the well content were diluted 1:100 in 0.9% NaCl. 
The obtained suspension was homogenised by vortex and 10 μl were spotted onto a TSA 
plate and left to dry. Following overnight incubation (18 ± 2 h), the number of colonies 
present on the plate was counted. CFU enumeration was determined as follows: 
 
 
 
 
 
CFU/ml = number of colonies x dilution factor (100) x 100 
